0001683168-23-000747.txt : 20230210 0001683168-23-000747.hdr.sgml : 20230210 20230210170035 ACCESSION NUMBER: 0001683168-23-000747 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NeoVolta Inc. CENTRAL INDEX KEY: 0001748137 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 825299263 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41447 FILM NUMBER: 23613135 BUSINESS ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 BUSINESS PHONE: 800-364-5464 MAIL ADDRESS: STREET 1: 13651 DANIELSON STREET STREET 2: SUITE A CITY: POWAY STATE: CA ZIP: 92064 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta, Inc. DATE OF NAME CHANGE: 20220613 FORMER COMPANY: FORMER CONFORMED NAME: NeoVolta Inc. DATE OF NAME CHANGE: 20180725 10-Q 1 neovolta_i10q-123122.htm FORM 10-Q
0001748137 false --06-30 2023 Q2 No No 0001748137 2022-07-01 2022-12-31 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2022-07-01 2022-12-31 0001748137 2023-02-10 0001748137 2022-12-31 0001748137 2022-06-30 0001748137 2022-10-01 2022-12-31 0001748137 2021-10-01 2021-12-31 0001748137 2021-07-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001748137 us-gaap:RetainedEarningsMember 2022-06-30 0001748137 us-gaap:CommonStockMember 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-09-30 0001748137 2022-09-30 0001748137 us-gaap:CommonStockMember 2021-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001748137 us-gaap:RetainedEarningsMember 2021-06-30 0001748137 2021-06-30 0001748137 us-gaap:CommonStockMember 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-09-30 0001748137 2021-09-30 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001748137 2022-07-01 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001748137 2021-07-01 2021-09-30 0001748137 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-12-31 0001748137 us-gaap:CommonStockMember 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-12-31 0001748137 2021-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:OneDealerMember 2022-07-01 2022-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:AnotherDealerMember 2022-07-01 2022-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:ThridDealerMember 2022-07-01 2022-12-31 0001748137 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember NEOV:TwoDealersMember 2022-07-01 2022-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:OneDealerMember 2021-07-01 2021-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerTwoMember 2021-07-01 2021-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerThreeMember 2021-07-01 2021-12-31 0001748137 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember NEOV:DealerFourMember 2021-07-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsUnderwritersMember 2022-07-01 2022-12-31 0001748137 us-gaap:RestrictedStockMember 2022-07-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2022-08-01 2022-08-31 0001748137 2022-08-01 2022-08-31 0001748137 2022-08-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-01 2021-10-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-31 0001748137 us-gaap:IPOMember 2022-07-01 2022-12-31 0001748137 us-gaap:IPOMember 2022-12-31 0001748137 NEOV:PublicOfferingMember 2022-07-01 2022-12-31 0001748137 us-gaap:WarrantMember 2022-12-31 0001748137 us-gaap:ConvertibleDebtMember 2022-07-01 2022-12-31 0001748137 NEOV:ConvertibleDebt1Member 2022-07-01 2022-12-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2022-12-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2022-08-01 2022-12-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2022-07-01 2022-12-31 0001748137 NEOV:AmortizedValueOfNewCompensationPlanMember 2022-07-01 2022-12-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2022-07-01 2022-12-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2022-07-01 2022-12-31 0001748137 NEOV:ThreeGranteesMember 2022-07-01 2022-12-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2021-07-01 2021-12-31 0001748137 NEOV:FairValueOfBonusSharesEarnedMember 2021-07-01 2021-12-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToAttorneyMember 2021-07-01 2021-12-31 0001748137 NEOV:AmortizedValueOfSharesToNewIndependentDirectorMember 2021-07-01 2021-12-31 0001748137 NEOV:FairValueOfIncentiveSharesWholesaleDealerMember 2021-07-01 2021-12-31 0001748137 NEOV:StockOptionPlan2019Member 2019-02-28 0001748137 us-gaap:RestrictedStockUnitsRSUMember NEOV:TwoExecutivesMember 2019-02-01 2022-12-31 0001748137 NEOV:PublicInvestorsMember 2022-07-01 2022-12-31 0001748137 NEOV:UnderwritersMember 2022-07-01 2022-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period Ended December 31, 2022

 

or

 

Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from ________________ to ______________

 

Commission File Number: 001-41447

 

 

NeoVolta, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   82-5299263

(State or other jurisdiction

of incorporation)

 

(I.R.S. Employer

Identification No.)

 

13651 Danielson Street, Suite A

Poway, CA

  92064

(Address of principal

executive offices)

  (zip code)

 

Registrant’s telephone number, including area code: (800) 364-5464

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol (s) Name of each exchange on which registered
Common Stock, par value $0.001 per share NEOV The NASDAQ Stock Market LLC
Warrants, each warrant exercisable for one share of common stock NEOVW The NASDAQ Stock Market LLC

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes: ☒No: ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes: ☒ No: ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐        Accelerated filer ☐     
Non-accelerated filer ☒       Smaller reporting company
   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) Yes ☐ No

 

The number of shares outstanding of Common Stock, par value $0.001 per share, as of February 10, 2023, was 33,145,368 shares.

 

 

 

   

 

 

NEOVOLTA, INC.

FORM 10-Q

DECEMBER 31, 2022

 

INDEX

 

  Page
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS 3
   
PART I. FINANCIAL INFORMATION 4
   
Item 1. Financial Statements  
Balance Sheets as of December 31, 2022 (Unaudited) and June 30, 2022 4
Statements of Operations for the three months ended December 31, 2022 and 2021 (Unaudited) 5
Statements of Operations for the six months ended December 31, 2022 and 2021 (Unaudited) 6

Statements of Stockholders’ Equity for the six months ended December 31, 2022 and 2021 (Unaudited)

7

Statements of Cash Flows for the six months ended December 31, 2022 and 2021 (Unaudited)

8
Notes to Financial Statements (Unaudited) 9
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3. Quantitative and Qualitative Disclosures About Market Risk 19
Item 4. Controls and Procedures 19
   

PART II. OTHER INFORMATION

 

21
Item 1. Legal Proceedings 21
Item 1A. Risk Factors 21
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22
Item 3. Defaults Upon Senior Securities 22
Item 4. Mine Safety Disclosures 22
Item 5. Other Information 22
Item 6. Exhibits 22
Signatures 23

 

 

 

 

 

 2 

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We make forward-looking statements under the “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in other sections of this Report. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this Report. 

 

You should read the matters described in, and incorporated by reference in, “Risk Factors” and the other cautionary statements made in this Report, as being applicable to all related forward-looking statements wherever they appear in this Report. We cannot assure you that the forward-looking statements in this Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements.

 

All forward-looking statements speak only at the date of the filing of this Quarterly Report. You should not rely upon forward-looking statements as predictions of future events. The reader should not place undue reliance on these forward-looking statements. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we provide no assurance that these plans, intentions or expectations will be achieved. We disclose important factors that could cause our actual results to differ materially from our expectations under “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in this Quarterly Report and our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022. These cautionary statements qualify all forward-looking statements attributable to us or persons acting on our behalf. We do not undertake any obligation to update or revise publicly any forward-looking statements except as required by law, including the securities laws of the United States and the rules and regulations of the SEC.

 

 

 

 

 

 

 3 

 

PART I . FINANCIAL INFORMATION 

 

NEOVOLTA, INC.

Balance Sheets

 

   December 31,   June 30, 
   2022   2022 
   (Unaudited)     
Assets
Current assets:          
Cash and cash equivalents  $3,422,697   $330,385 
Accounts receivable, net   1,811,173    1,317,738 
Inventory   1,738,936    2,238,208 
Prepaid insurance and other current assets   276,472    239,001 
Total current assets   7,249,278    4,125,332 
           
Total assets  $7,249,278   $4,125,332 
           
Liabilities and Stockholders' Equity          
Current liabilities:          
Accounts payable  $29,610   $205,600 
Accrued interest payable       53,436 
Other accrued liabilities   17,757    127,356 
Convertible notes payable       1,068,000 
Total current liabilities   47,367    1,454,392 
           
Convertible notes payable       53,716 
Total liabilities   47,367    1,508,108 
           
Commitments and contingencies (Note 4)        
           
Stockholders' equity:          
Common stock, $0.001 par value, 100,000,000 shares authorized, 32,845,368 and 21,977,251 shares issued and outstanding  
 
 
 
 
32,846
 
 
 
 
 
 
 
21,978
 
 
Additional paid-in capital   24,654,575    18,394,641 
Accumulated deficit   (17,485,510)   (15,799,395)
Total stockholders' equity   7,201,911    2,617,224 
           
Total liabilities and stockholders' equity  $7,249,278   $4,125,332 

 


See accompanying notes to unaudited financial statements.

 

 

 4 

 

 

NEOVOLTA, INC.

Statements of Operations

(Unaudited)

 

 

         
   Three Months Ended
December 31,
 
   2022   2021 
         
Revenues from contracts with customers  $567,105   $1,035,127 
Cost of goods sold   473,159    861,706 
Gross profit   93,946    173,421 
           
Operating expenses:          
General and administrative   1,073,729    4,137,495 
Research and development   7,746    62,250 
Total operating expenses   1,081,475    4,199,745 
           
Loss from operations   (987,529)   (4,026,324)
           
Other income (expense):          
Interest expense       (3,530)
Total other income (expense)       (3,530)
           
Net loss  $(987,529)  $(4,029,854)
           
Weighted average shares outstanding - basic and diluted   32,822,542    19,998,683 
           
Net loss per share - basic and diluted  $(0.03)  $(0.20)

 

See accompanying notes to unaudited financial statements.

 

 

 

 5 

 

 

 

NEOVOLTA, INC.

Statements of Operations

(Unaudited)

 

 

         
   Six Months Ended
December 31,
 
   2022   2021 
         
Revenues from contracts with customers  $2,104,941   $2,634,731 
Cost of goods sold   1,765,119    2,222,700 
Gross profit   339,822    412,031 
           
Operating expenses:          
General and administrative   1,993,157    4,494,053 
Research and development   28,646    66,503 
Total operating expenses   2,021,803    4,560,556 
           
Loss from operations   (1,681,981)   (4,148,525)
           
Other income (expense):          
Interest expense   (4,134)   (9,536)
Total other income (expense)   (4,134)   (9,536)
           
Net loss  $(1,686,115)  $(4,158,061)
           
Weighted average shares outstanding - basic and diluted   30,916,212    19,982,352 
           
Net loss per share - basic and diluted  $(0.05)  $(0.21)

 

 

See accompanying notes to unaudited financial statements.

 

 

 6 

 

 

 

NEOVOLTA, INC.

Statements of Stockholders' Equity

Six Months Ended December 31, 2022 and 2021

(Unaudited)

 

                          
           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2022   21,977,251   $21,978   $18,394,641   $(15,799,395)  $2,617,224 
                          
Issuance of common stock in underwritten public offering   1,121,250    1,121    3,779,284        3,780,405 
Issuance of common stock for conversion of debt and accrued interest   9,671,867    9,672    1,169,614        1,179,286 
Stock compensation expense           591,816        591,816 
Net loss               (698,586)   (698,586)
                          
Balance at September 30, 2022   32,770,368    32,771    23,935,355    (16,497,981)   7,470,145 
                          
Stock compensation expense   75,000    75    719,220        719,295 
Net loss               (987,529)   (987,529)
                          
Balance at December 31, 2022   32,845,368   $32,846   $24,654,575   $(17,485,510)  $7,201,911 

 

           Additional       Total 
   Common Stock   Paid-in   Accumulated   Stockholders' 
   Shares   Amount   Capital   Deficit   Equity 
                     
Balance at June 30, 2021   19,640,888   $19,641   $13,169,363   $(10,040,370)  $3,148,634 
                          
Issuance of common stock for conversion of debt and accrued interest   203,630    204    1,079        1,283 
Stock compensation expense   154,165    154    130,469        130,623 
Adjustment for change in accounting principle           (87,116)   45,809    (41,307)
Net loss               (128,207)   (128,207)
                          
Balance at September 30, 2021   19,998,683    19,999    13,213,795    (10,122,768)   3,111,026 
                          
Stock compensation expense           3,870,935        3,870,935 
Net loss               (4,029,854)   (4,029,854)
                          
Balance at December 31, 2021   19,998,683   $19,999   $17,084,730   $(14,152,622)  $2,952,107 

 

See accompanying notes to unaudited financial statements.

 

 

 

 7 

 

 

NEOVOLTA, INC.

Statements of Cash Flows

(Unaudited)

 

           
   Six Months Ended
December 31,
 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(1,686,115)  $(4,158,061)
Adjustments to reconcile net loss to net cash used in operations:          
Stock compensation expense   1,311,111    4,001,558 
Bad debt expense   80,000     
Changes in current assets and liabilities          
Accounts receivable   (573,435)   (325,004)
Inventory   499,272    126,609 
Prepaid insurance and other current assets   (37,471)   (72,617)
Accounts payable   (175,990)   (43,160)
Accrued expenses   (105,465)   197 
Other, net       (5,445)
Net cash flows used in operating activities   (688,093)   (475,923)
           
Cash flows from financing activities:          
Underwritten public offering of common stock   3,780,405     
Proceeds from convertible notes payable       1,068,000 
Net cash flows provided by financing activities   3,780,405    1,068,000 
           
Net increase in cash and cash equivalents   3,092,312    592,077 
           
Cash and cash equivalents at beginning of period   330,385    425,681 
           
Cash and cash equivalents at end of period  $3,422,697   $1,017,758 
           
Supplemental disclosures of cash flow information          
Cash paid for interest  $   $ 
Cash paid for income taxes        
           
Supplemental non-cash financing activities          
Conversion of convertible debt and accrued interest into common stock   $ 1,179,286     $ 1,283  
Adjustment of debt discount related to adoption of new accounting principle           87,116  

 

 

See accompanying notes to unaudited financial statements.

 

 

 

 

 8 

 

 

NEOVOLTA, INC.

Notes to Financial Statements

(Unaudited)

 

 

(1) Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of December 31, 2022, the results of its operations for the three and six month periods ended December 31, 2022 and 2021, the changes in its stockholders’ equity for the six month periods ended December 31, 2022 and 2021, and cash flows for the six month periods ended December 31, 2022 and 2021. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. The amount in excess of the FDIC insurance at December 31, 2022 was $3,172,697.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of December 31, 2022 and June 30, 2022:

 

Schedule of inventory  December 31,
2022
   June 30,
2022
 
Raw materials  $1,676,141   $1,844,049 
Work in process   62,795    22,768 
Finished goods       371,391 
           
Total  $1,738,936   $2,238,208 

  

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of December 31, 2022 and June 30, 2022.

 

 

 

 9 

 

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 27%, 19% and 12% of the Company’s revenues in the six months ended December 31, 2022, however, no other dealers accounted for more than 10% of the revenues in such period. Two of those same two dealers represented an aggregate of approximately 61% of the Company’s accounts receivable as of December 31, 2022 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of December 31, 2022. Four dealers represented approximately 17%, 15%, 13% and 12% of the Company’s revenues in the six months ended December 31, 2021. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the six months ended December 31, 2022 and 2021 is provided.

 

Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of December 31, 2022 and June 30, 2022, our allowance for doubtful accounts was $80,000 and zero, respectively.

 

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2022, the Company had total outstanding common stock equivalents of 1,529,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) 350,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 3).

 

 

 

 

 10 

 

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. 

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. 

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.

 

At December 31, 2022 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

 

 

 11 

 

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. With the proceeds of this equity offering, we anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

 

(2)        Notes Payable

 

In conjunction with the closing of our underwritten public offering in August 2022 (see Note 3), all holders of the Company’s two outstanding series of convertible notes payable, which were originally issued to various accredited investors in May 2018 and October 2021, agreed to convert their debt into a total of 9,671,867 shares of our common stock at the respective conversion rates. Each of these two series of our converted notes payable is further described below.

 

In May 2018, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $104,688. Each unsecured note originally bore interest at a rate of 12% per annum, which was later reduced by mutual agreement to 3.99% per annum in May 2019. Subsequently, the holders of certain of these notes elected to convert or exchange certain portions of their convertible notes payable into shares of our common stock, based upon the stated conversion rate of $0.0063 per share. As of the closing of our underwritten public offering in August 2022, the holders of the remaining balance of such unconverted notes in the total amount of $59,251, including accrued interest, agreed to convert their debt into a total of 9,404,867 shares of our common stock at the stated conversion rate of $0.0063 per share.

 

In October 2021, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $1,068,000. Each unsecured note bore interest at a rate of 6% per annum. As of the closing of our underwritten public offering in August 2022, pursuant to the terms of such convertible notes, the notes were automatically converted into a total of 267,000 shares of our common stock at the stated conversion rate of $4.00 of principal per share.

 

(3)        Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

 

 

 12 

 

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate (see Note 2).

 

In the six months ended December 31, 2021, the holders of the 2018 convertible notes payable having total principal and accrued interest balances in the aggregate amount of $1,283 elected to convert their notes. Based upon the stated conversion price of $0.0063 per share, these holders converted their notes payable into a total of 203,630 shares of common stock (see Note 2).

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

 

The following table presents activity with respect to the Company’s warrants for the six months ended December 31, 2022:

 

Schedule of warrants activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at July 1, 2022                  
Warrants issued to Public Investors   1,121,250    4.00           
Warrants issued to Underwriters   58,500    4.40           
Outstanding at December 31, 2022   1,179,750    4.02    4.5   $ 
                     
Exercisable at December 31, 2022   1,179,750    4.02    4.5   $ 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of January 1, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to the CEO as of that date.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to the CFO as of that date.

 

 

 

 13 

 

 

Based upon the Company’s assessment of the probability of the CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, the Company has calculated the grant date value of such awards and is amortizing it as stock compensation expense over the underlying performance periods. The Company has recognized stock compensation expense applicable to such RSU awards in the six months ended December 31, 2022 in the amount of $1,159,882.

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of December 31, 2022, we booked an initial accrual of $97,500 of compensation expense (of which $87,750 will be settled through the issuance of shares) for our three independent directors under this plan. At the same time, we also granted 26,000 shares, with a grant date value of $97,500, to various advisors pursuant to annual contracts for their services. In the six months ended December 31, 2022, we recognized total non-cash stock compensation expense of $1,311,111 as follows: (i) $1,159,882 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $87,750 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $48,750 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $14,729 for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2022 (see Note 4). There was a total of 75,000 shares of common stock that were issued to three grantees, a director and two advisory board members, in the six months ended December 31, 2022, which were previously expensed in the year ended June 30, 2022.

 

In the six months ended December 31, 2021, the Company recognized non-cash stock compensation expense in the total amount of $4,001,558 as follows: (i) $3,505,000 for the fair value of 500,000 incentive shares earned as of December 31, 2021 by a company controlled by the Company’s CEO under a previous compensation plan (which were not issued until early 2022); (ii) $175,250 for the fair value of 25,000 bonus shares earned as of December 31, 2021 by an outside attorney (which were not issued until early 2022); (iii) $157,746 for the amortized value of 50,000 shares granted to an attorney and a consultant pursuant to one year service agreements in mid 2021; (iv) $103,500 for the amortized value of 50,000 shares attributable to a new independent director in early 2021; and (v) $60,062 for the fair value of 8,568 incentive shares earned by a wholesale dealer as of December 31, 2021 (see Note 4). There was a total of 154,165 shares of common stock that were issued to various grantees, primarily advisors, attorneys and consultants, in the six months ended December 31, 2021.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of December 31, 2022, the Company has made awards totaling 450,000 shares for the RSUs granted to two executives, as noted above, under the Plan.

 

(4)       Commitments and Contingencies

 

Effective January 1, 2021, the Company secured new corporate and manufacturing office space under a sublease agreement with its contract manufacturer. Under the terms of the sublease agreement, the Company is required to make rental payments of $10,350 per month during the initial one-year term of the agreement. The sublease agreement is renewable upon mutual agreement of both parties for up to four additional years at a modest increase in the monthly rent, however, the Company is under is no obligation to renew it. Management has determined that the exercise of the renewal option is not reasonably certain and, as such, the Company has accounted for it as a short-term lease under ASC 842, Leases. Effective January 1, 2023, the Company elected to renew the agreement for another one year period.

 

As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums.

 

 

 

 14 

 

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

(5)        Subsequent Events

 

As of January 1, 2023, we issued a total of 300,000 shares of common stock to our two executive officers in recognition of each officer having achieved Milestone 1 under their respective Board approved RSU awards (see Note 3).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 15 

 

 

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Introduction

 

This information should be read in conjunction with the interim unaudited financial statements and the notes thereto included in this Quarterly Report on Form 10-Q, and the audited financial statements and notes thereto and “Part II. Other Information - Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”, contained in our Annual Report on Form 10-K for the year ended June 30, 2022, filed with the Securities and Exchange Commission on September 27, 2022 (the “Annual Report”).

 

Certain capitalized terms used below and otherwise defined below, have the meanings given to such terms in the footnotes to our unaudited financial statements included above under “Part I - Financial Information” - “Item 1. Financial Statements”.

 

Unless the context requires otherwise, references to the “Company,” “we,” “us,” “our,” “NEOV”, refer specifically to NeoVolta, Inc.

 

In addition, unless the context otherwise requires and for the purposes of this Report only:

 

·“Exchange Act” refers to the Securities Exchange Act of 1934, as amended; 

 

·“SEC” or the “Commission” refers to the United States Securities and Exchange Commission; and 

 

·“Securities Act” refers to the Securities Act of 1933, as amended. 

 

Overview

 

We are a designer, manufacturer, and seller of high-end Energy Storage Systems (or ESS), primarily our NeoVolta NV14 and NV 24, which can store and use energy via batteries and an inverter at residential or commercial sites. We were founded to identify new ways to leverage emerging technologies with the dynamic changes that are taking place in the energy delivery space. We primarily market and sell our products directly to our certified solar installers and solar equipment distributors. We are also pursuing agreements with residential developers, commercial developers, and other commercial opportunities. Because we are purely dedicated to energy solar systems, virtually all of our current resources and efforts go into further developing our flagship NV14 and NV 24 products, while focusing on specific industry needs for our next generation of products. We believe we are unique in the marketplace due to our low cost, our innovative battery chemistry, our product versatility and our commitment to installer service. Because of these factors, we believe NeoVolta is uniquely equipped to establish itself as a major player in the energy storage market.

 

In May 2019, we completed a public offering of 3,500,000 shares of our common stock at an offering price of $1.00 per share for gross proceeds of $3.5 million pursuant to Regulation A of the Securities Act.. We used the proceeds of the offering to ramp up production, marketing, and sales of our NV14 product line. In that regard, we have used the proceeds from the offering to fund the marketing, production and distribution of our products, which commenced in July 2019 through a group of wholesale customers in California, as well as to provide additional working capital for other corporate purposes. We have expanded to include one wholesale distribution customer in Nevada. As of the current date, we have had successful installations of our products in the additional States of Arizona, Nevada, Georgia, Utah, Florida, Puerto Rico, Oklahoma, Texas, Colorado, Wyoming, Tennessee, and Missouri.

 

As further discussed below under “Underwritten Public Offering,” we completed an underwritten public offering of our equity securities in the form of Units in August 2022. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

 

 

 

 16 

 

 

Underwritten Public Offering

 

In early August 2022, we completed an underwritten public offering of our equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market under the symbols “NEOV” and “NEOVW,” respectively. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

Between the initial closing of the offering and the underwriters’ exercise of the overallotment option, we sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering, including the underwriters’ exercise of the overallotment option, were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000. We are using the proceeds of this public offering to increase our current production capacity, expand our product portfolio, enlarge our product marketing and sales efforts, and for other general corporate purposes.

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate. As a result of the simultaneous conversion of both sets of convertible notes, the Company has fully eliminated its convertible debt.

 

Results of Operations

 

The following discussion reflects the Company’s revenues and expenses for the three and six month periods ended December 31, 2022 and 2021, as reported in our financial statements included in Item 1.

 

Three months ended December 31, 2022 versus three months ended December 31, 2021

 

Revenues - Revenues from contracts with customers for the three months ended December 31, 2022 were $567,105 compared to $1,035,127 for the three months ended December 31, 2021. Such decrease was primarily due to the pendency of the April 2023 effective date of new utility regulations in the State of California that we believe is presently causing an economic disincentive for residential utility customers to acquire our energy storage systems prior to the effective date of those regulations (see “Item 1A. Risk Factors” for a discussion of the new utility regulations).

 

Cost of Goods Sold - Cost of goods sold for the three months ended December 31, 2022 were $473,159 compared to $861,706 for the three months ended December 31, 2021. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 17% in both periods.

 

General and Administrative Expense - General and administrative expenses for the three months ended December 31, 2022 were $1,073,729 compared to $4,137,495 for the three months ended December 31, 2021. Such decrease was primarily due to the reduction in the expense recorded for the fair value of incentive shares of common stock earned by the Company’s executive officers under their new employment contracts, effective in March 2022.

 

Research and Development Expense - Research and development expenses for the three months ended December 31, 2022 were $7,746 compared to $62,250 for the three months ended December 31, 2021. Such fluctuation was due to a decrease in the level of the Company’s recent product development efforts.

 

Interest Expense - Interest expense for the three months ended December 31, 2022 was zero compared to $3,530 for the three months ended December 31, 2021. This decrease resulted from the conversion of our 2018 and 2021 convertible notes in conjunction with the closing of our public offering in August 2022.

 

 

 

 17 

 

 

Net Loss - Net loss for the three months ended December 31, 2022 was $987,529 compared to $4,029,854 for the three months ended December 31, 2021, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

Six months ended December 31, 2022 versus six months ended December 31, 2021

 

Revenues - Revenues from contracts with customers for the six months ended December 31, 2022 were $2,104,941 compared to $2,634,731 for the six months ended December 31, 2021. Such decrease was primarily due to the pendency of the April 2023 effective date of new utility regulations in the State of California that we believe is presently causing an economic disincentive for residential utility customers to acquire our energy storage systems prior to the effective date of those regulations (see “Item 1A. Risk Factors” for a discussion of the new utility regulations).

 

Cost of Goods Sold - Cost of goods sold for the six months ended December 31, 2022 were $1,765,119 compared to $2,222,700 for the six months ended December 31, 2021. The cost of goods sold in both periods reflected the cost of procuring and assembling the component parts of the energy storage systems that were sold in each fiscal year and resulted in gross profits on such sales of approximately 16% in both periods.

 

General and Administrative Expense - General and administrative expenses for the six months ended December 31, 2022 were $1,993,157 compared to $4,494,053 for the six months ended December 31, 2021. Such decrease was primarily due to the reduction in the expense recorded for the fair value of incentive shares of common stock earned by the Company’s executive officers under their new employment contracts, effective in March 2022.

 

Research and Development Expense - Research and development expenses for the six months ended December 31, 2022 were $28,646 compared to $66,503 for the six months ended December 31, 2021. Such fluctuation was due to a decrease in the level of the Company’s recent product development efforts.

 

Interest Expense - Interest expense for the six months ended December 31, 2022 was $4,134 compared to $9,536 for the six months ended December 31, 2021. This decrease resulted from the conversion of our 2018 and 2021 convertible notes in conjunction with the closing of our public offering in August 2022.

 

Net Loss - Net loss for the six months ended December 31, 2022 was $1,686,115 compared to $4,158,061 for the six months ended December 31, 2021, representing the aggregate of the various revenue and expense categories indicated above. The Company has not recognized any income tax benefit for these net losses due to the uncertainty of its ultimate realization.

 

Liquidity and Capital Resources

 

Operating activities. Net cash used in operating activities in the six months ended December 31, 2022 was $688,093, compared to $475,923 in the six months ended December 31, 2021, reflecting a modest increase in net working capital requirements in the current fiscal year period.

 

Financing activities. Net cash provided by financing activities in the six months ended December 31, 2022 was $3,780,405, compared to $1,068,000 in the six months ended December 31, 2021. As further discussed below, our net cash provided by financing activities in the six months ended December 31, 2022 was entirely attributable to the successful completion of an underwritten public offering of our equity securities in early August 2022. Our net cash provided by financing activities in the six months ended December 31, 2021 resulted from the issuance of our convertible notes payable to a group of accredited investors in October 2021 in the amount of $1,068,000. Such notes were ultimately converted into common stock in conjunction with the closing of our public offering in August 2022.

 

We completed an underwritten public offering of our equity securities in the form of Units in early August 2022. Each Unit consisted of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $4.00 per share. We sold a total of 1,121,250 Units in the offering at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering, including the underwriters’ exercise of the overallotment option, were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs, were approximately $3,780,000.

 

 

 

 18 

 

 

In conjunction with the public offering, all holders of our 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of our 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate. As a result of the simultaneous conversion of both sets of convertible notes, the Company has fully eliminated its convertible debt.

 

As of December 31, 2022, we had a cash balance of $3.4 million and net working capital of approximately $7.2 million. Currently, we are not generating a break-even level of net operating cash flow from our net sales. However, we anticipate that demand for our products will ultimately increase over time and that we will have sufficient cash to operate for at least the next 12 months.

 

Recent Developments

 

As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. In calendar year 2022, we have experienced some negative impact of the COVID-19 pandemic on the sales of our assembled energy storage systems, primarily through a group of wholesale dealers and installers located in California. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities which would be considered off-balance sheet arrangements as defined in Item 303 of Regulation S-K.

 

 

Critical Accounting Policies and Estimates

 

Our discussion and analysis of our financial condition and results of operations are based on financial statements which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We believe that certain accounting policies affect our more significant judgments and estimates used in the preparation of our financial statements. See “Note 1. Business and Summary of Significant Accounting Policies” of the Notes to Financial Statements set forth above and under “Item 8. Financial Statements and Supplementary Data” of our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022, for a further description of our critical accounting policies and estimates.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Information for this Item is not required as the Registrant is a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act.

 

ITEM 4.CONTROLS AND PROCEDURES

 

Evaluation of disclosure controls and procedures

 

We have established and maintain a system of disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our reports filed with the Securities and Exchange Commission pursuant to the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Commission and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial and accounting officer, to allow timely decisions regarding required disclosures.

 

As of December 31, 2022, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as a result of the material weakness relating to the lack of segregation of duties, our disclosure controls and procedures as of the end of the period covered by this Quarterly Report were not effective. Due to our size and nature, segregation of all conflicting duties may not always be possible and may not be economically feasible. We will be required to hire additional personnel in order to remediate our material weakness.

 

 

 

 19 

 

 

Changes in internal controls over financial reporting

 

There was no change in our internal controls over financial reporting that occurred during the quarter ended December 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

 

 

 

 

 

 

 

 

 

 

 20 

 

 

PART II.      OTHER INFORMATION

 

 

ITEM 1.LEGAL PROCEEDINGS

 

Although we may, from time to time, be involved in litigation and claims arising out of our operations in the normal course of business, we are not currently a party to any material legal proceeding. In addition, we are not aware of any material legal or governmental proceedings against us, or contemplated to be brought against us.

 

ITEM 1A.RISK FACTORS

 

There have been no material changes from the risk factors previously disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022 (the “Form 10-K”), under the heading “Risk Factors”, except as set forth below, which are incorporated by reference herein and investors should review the risks provided in the Form 10-K prior to making an investment in the Company. The business, financial condition and operating results of the Company can be affected by a number of factors, whether currently known or unknown, including but not limited to those described in the Form 10-K for the year ended June 30, 2022, under “Risk Factors”, any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past, or from anticipated future, financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results and stock price.

 

The following are new risk factors which supplements the risk factors included in our Form 10-K:

 

Recent utility regulations enacted in the State of California in December 2022 are currently having a negative impact on the sales of our energy storage systems in that state.

 

On December 15, 2022, the California Public Utilities Commission (“CPUC”) unanimously passed a new statewide utility regulation known as Net Energy Metering 3.0 (“NEM 3.0”). This new regulation will become effective in 120 days after enactment, on April 14, 2023, and will significantly alter the net billing rates for residential solar production in the State of California and ultimately impact the monthly energy bill savings for homeowners. We believe that the passage of NEM 3.0 will provide a significant economic incentive for residential utility customers to acquire energy storage systems, such as those sold by NeoVolta, once NEM 3.0 becomes effective on April 14, 2023. In the meantime, however, there is an impediment for residential utility customers to acquire our energy storage systems, which are presently being grandfathered under a similar new regulation for solar panels, until the purchasing and installation of batteries can occur in advance of NEM 3.0 becoming effective on April 14, 2023. Therefore, we expect the negative impact that we are currently experiencing on our sales in the State of California to possibly continue through at least the first calendar quarter of 2023.

 

An increase in mortgage interest rates may result in a decrease in demand by homeowners for our residential energy storage systems.

 

Sales volume in our homeowner channel is partially dependent on the construction of new homes and the sale of existing homes in our residential markets. Many customers of our installation partners rely on mortgage loans from banks and other lenders in order to finance a substantial portion of the purchase price for their home, including any related improvements. Increased mortgage interest rates may lead to lower demand for new homes and a reduced number of homes available for solar origination through our homeowner channel. Additionally, increased interest rates may result in fewer secondary home sales, a reduction in the number of customers refinancing their mortgages and uncertainty about the economy.

 

 

 21 

 

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There have been no sales of unregistered securities during the three months ended December 31, 2022.

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4.MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5.OTHER INFORMATION

 

None.

 

ITEM 6.EXHIBITS

 

 

Exhibit No.   Exhibit Description
31.1*   Certification of Principal Executive Officer Pursuant to Section 302 of Sarbanes- Oxley Act of 2002
31.2*   Certification of Principal Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer Pursuant to Section 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS *   Inline XBRL Instance Document
101.SCH *   Inline XBRL Taxonomy Extension Schema Document
101.CAL *   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF *   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB *   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE *   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

______________________

* Filed herewith.

 

 

 

 22 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

  NEOVOLTA, INC.
   
February 10, 2023 /s/ Brent S. Willson                 
  Brent S. Willson
  Chief Executive Officer
  (Principal Executive Officer)
   
February 10, 2023 /s/ Steve Bond                        
  Steve Bond
  Chief Financial Officer
  (Principal Financial/Accounting Officer)
   
   
   
   

 

 

 

 23 

 

 

 

 

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-31.1 3 neovolta_ex3101.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION

 

I, Brent S. Willson, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 10, 2023

 

  /s/ Brent S. Willson
  Brent S. Willson
  Chief Executive Officer
  (Principal Executive Officer)

 

EX-31.2 4 neovolta_ex3102.htm CERTIFICATION

Exhibit 31.2

 

CERTIFICATION

 

I, Steve Bond, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q of NeoVolta, Inc. (the “registrant”);

 

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)[Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942];

 

c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

 

a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 10, 2023

 

  /s/ Steve Bond
  Steve Bond
  Chief Financial Officer
  (Principal Financial/Accounting Officer)

EX-32.1 5 neovolta_ex3201.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brent S. Willson, Chief Executive Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

  /s/ Brent S. Willson
  Brent S. Willson
  Chief Executive Officer
  (Principal Executive Officer)
  February 10, 2023

 

EX-32.2 6 neovolta_ex3202.htm CERTIFICATION

Exhibit 32.2

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of NeoVolta, Inc. (the “registrant”) on Form 10-Q for the quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Steven Bond, Chief Financial Officer of the registrant, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of this Sarbanes Oxley Act of 2002, that, to my knowledge:

 

(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and

 

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the registrant at the dates and for the periods indicated.

 

 

  /s/ Steve Bond
  Steve Bond
  Chief Financial Officer
  (Principal Financial/Accounting Officer)
  February 10, 2023

 

EX-101.SCH 7 neov-20221231.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Business and Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Notes Payable link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Notes Payable (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Equity (Details - Warrant activity) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 neov-20221231_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 neov-20221231_def.xml XBRL DEFINITION FILE EX-101.LAB 10 neov-20221231_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.001 per share Warrants, each warrant exercisable for one share of common stock Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Customer [Axis] One Dealer [Member] Another Dealer [Member] Thrid Dealer [Member] Accounts Receivable [Member] Two Dealers [Member] Dealer Two [Member] Dealer Three [Member] Dealer Four [Member] Antidilutive Securities [Axis] Warrants [Member] Warrants Underwriters [Member] Restricted Stock [Member] Long-Term Debt, Type [Axis] Convertible Debt [Member] Sale of Stock [Axis] IPO [Member] Securities Financing Transaction [Axis] Public Offering [Member] Warrant [Member] Convertible Debt 1 [Member] Counterparty Name [Axis] Three Independent Directors [Member] Transaction Type [Axis] Amortized Value of RSUs Granted [Member] Amortized Value Of New Compensation Plan [Member] Amortized Value Of Shares Granted To Various Advisors [Member] Fair Value Of Incentive Shares [Member] Three Grantees [Member] Fair Value Of Bonus Shares Earned [Member] Amortized Value Of Shares Granted To Attorney [Member] Amortized Value Of Shares To New Independent Director [Member] Fair Value Of Incentive Shares Wholesale Dealer [Member] Plan Name [Axis] 2019 Stock Option Plan [Member] Award Type [Axis] Restricted Stock Units (RSUs) [Member] Two Executives [Member] Public Investors [Member] Underwriters [Member] Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] Assets Current assets: Cash and cash equivalents Accounts receivable, net Inventory Prepaid insurance and other current assets Total current assets Total assets Liabilities and Stockholders' Equity Current liabilities: Accounts payable Accrued interest payable Other accrued liabilities Convertible notes payable Total current liabilities Convertible notes payable Total liabilities Commitments and contingencies (Note 4) Stockholders' equity: Common stock, $0.001 par value, 100,000,000 shares authorized, 32,845,368 and 21,977,251 shares issued and outstanding Additional paid-in capital Accumulated deficit Total stockholders' equity Total liabilities and stockholders' equity Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues from contracts with customers Cost of goods sold Gross profit Operating expenses: General and administrative Research and development Total operating expenses Loss from operations Other income (expense): Interest expense Total other income (expense) Net loss Gross profit Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Earnings Per Share, Basic Earnings Per Share, Diluted Beginning balance, value Shares, Outstanding, Beginning Balance Issuance of common stock in underwritten public offering Issuance of common stock in underwritten public offering, shares Issuance of common stock for conversion of debt and accrued interest Issuance of common stock for conversion of debt and accrued interest, shares Stock compensation expense Net loss Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture Adjustment for change in accounting principle Stock compensation expense, shares Ending balance, value Shares, Outstanding, Beginning Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operations: Stock compensation expense Bad debt expense Changes in current assets and liabilities Accounts receivable Inventory Prepaid insurance and other current assets Accounts payable Accrued expenses Other, net Net cash flows used in operating activities Cash flows from financing activities: Underwritten public offering of common stock Proceeds from convertible notes payable Net cash flows provided by financing activities Net increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Supplemental disclosures of cash flow information Cash paid for interest Cash paid for income taxes Supplemental non-cash financing activities Conversion of convertible debt and accrued interest into common stock Adjustment of debt discount related to adoption of new accounting principle Organization, Consolidation and Presentation of Financial Statements [Abstract] Business and Summary of Significant Accounting Policies Debt Disclosure [Abstract] Notes Payable Equity [Abstract] Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Description of Business Interim Financial Information Cash and Cash Equivalents Inventory Revenue Recognition Allowance for Doubtful Accounts Income Taxes Stock Compensation Expense Loss Per Common Share Research and Development Costs Use of Estimates Related Parties Fair Value Measurements and Financial Instruments Recent Accounting Pronouncements Liquidity Schedule of inventory Schedule of warrants activity Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Raw materials Work in process Finished goods Total Allowance for doubtful accounts Antidilutive shares Schedule of Product Information [Table] Product Information [Line Items] Cash, Uninsured Amount Inventory Valuation Reserves Concentration Risk, Percentage Liabilities, Fair Value Disclosure Assets, Fair Value Disclosure Schedule of Long-Term Debt Instruments [Table] Debt Instrument [Line Items] Number of shares converted Conversion of Stock, Amount Converted Shares converted Conversion price Proceeds from Convertible Debt Debt Instrument, Interest Rate, Stated Percentage Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Class of Warrant or Right, Outstanding Class of Warrant or Right, Exercise Price of Warrants or Rights [custom:WarrantsIssuedShares] Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Class of Warrant or Right, Outstanding Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants and Rights Outstanding, Term Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Warrant exercisable, shares Warrants exercisable, weighted average exercise price Warrants term, exercisable [custom:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable-0] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Subsidiary, Sale of Stock [Line Items] Exercise price Sale of Stock, Number of Shares Issued in Transaction Sale of Stock, Price Per Share Proceeds from Issuance Initial Public Offering Proceeds from Issuance or Sale of Equity Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Amounts converted Debt Conversion, Converted Instrument, Amount Number of shares exercisable Accrued compensation expenses Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture Share-Based Payment Arrangement, Noncash Expense Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Assets, Current Assets [Default Label] Liabilities, Current Convertible Notes Payable, Noncurrent Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses Operating Income (Loss) Interest Expense Nonoperating Income (Expense) Shares, Outstanding Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Insurance Increase (Decrease) in Accounts Payable Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Inventory, Policy [Policy Text Block] Class of Warrant or Right, Outstanding EX-101.PRE 11 neov-20221231_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Cover - shares
6 Months Ended
Dec. 31, 2022
Feb. 10, 2023
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Dec. 31, 2022  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --06-30  
Entity File Number 001-41447  
Entity Registrant Name NeoVolta, Inc.  
Entity Central Index Key 0001748137  
Entity Tax Identification Number 82-5299263  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 13651 Danielson Street  
Entity Address, Address Line Two Suite A  
Entity Address, City or Town Poway  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 92064  
City Area Code (800)  
Local Phone Number 364-5464  
Entity Current Reporting Status No  
Entity Interactive Data Current No  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Elected Not To Use the Extended Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   33,145,368
Common Stock, par value $0.001 per share    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol NEOV  
Security Exchange Name NASDAQ  
Warrants, each warrant exercisable for one share of common stock    
Title of 12(b) Security Warrants, each warrant exercisable for one share of common stock  
Trading Symbol NEOVW  
Security Exchange Name NASDAQ  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2022
Jun. 30, 2022
Current assets:    
Cash and cash equivalents $ 3,422,697 $ 330,385
Accounts receivable, net 1,811,173 1,317,738
Inventory 1,738,936 2,238,208
Prepaid insurance and other current assets 276,472 239,001
Total current assets 7,249,278 4,125,332
Total assets 7,249,278 4,125,332
Current liabilities:    
Accounts payable 29,610 205,600
Accrued interest payable 0 53,436
Other accrued liabilities 17,757 127,356
Convertible notes payable 0 1,068,000
Total current liabilities 47,367 1,454,392
Convertible notes payable 0 53,716
Total liabilities 47,367 1,508,108
Commitments and contingencies (Note 4)
Stockholders' equity:    
Common stock, $0.001 par value, 100,000,000 shares authorized, 32,845,368 and 21,977,251 shares issued and outstanding 32,846 21,978
Additional paid-in capital 24,654,575 18,394,641
Accumulated deficit (17,485,510) (15,799,395)
Total stockholders' equity 7,201,911 2,617,224
Total liabilities and stockholders' equity $ 7,249,278 $ 4,125,332
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Dec. 31, 2022
Jun. 30, 2022
Statement of Financial Position [Abstract]    
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 32,845,368 21,977,251
Common Stock, Shares, Outstanding 32,845,368 21,977,251
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Revenues from contracts with customers $ 567,105 $ 1,035,127 $ 2,104,941 $ 2,634,731
Cost of goods sold 473,159 861,706 1,765,119 2,222,700
Gross profit 93,946 173,421 339,822 412,031
Operating expenses:        
General and administrative 1,073,729 4,137,495 1,993,157 4,494,053
Research and development 7,746 62,250 28,646 66,503
Total operating expenses 1,081,475 4,199,745 2,021,803 4,560,556
Loss from operations (987,529) (4,026,324) (1,681,981) (4,148,525)
Other income (expense):        
Interest expense 0 (3,530) (4,134) (9,536)
Total other income (expense) 0 (3,530) (4,134) (9,536)
Net loss (987,529) (4,029,854) (1,686,115) (4,158,061)
Gross profit $ 93,946 $ 173,421 $ 339,822 $ 412,031
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Operations (Unaudited) (Parenthetical) - $ / shares
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]        
Weighted Average Number of Shares Outstanding, Basic 32,822,542 19,998,683 30,916,212 19,982,352
Weighted Average Number of Shares Outstanding, Diluted 32,822,542 19,998,683 30,916,212 19,982,352
Earnings Per Share, Basic $ (0.03) $ (0.20) $ (0.05) $ (0.21)
Earnings Per Share, Diluted $ (0.03) $ (0.20) $ (0.05) $ (0.21)
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jun. 30, 2021 $ 19,641 $ 13,169,363 $ (10,040,370) $ 3,148,634
Shares, Outstanding, Beginning Balance at Jun. 30, 2021 19,640,888      
Issuance of common stock for conversion of debt and accrued interest $ 204 1,079 1,283
Issuance of common stock for conversion of debt and accrued interest, shares 203,630      
Stock compensation expense $ 154 130,469 130,623
Net loss (128,207) (128,207)
Adjustment for change in accounting principle (87,116) 45,809 (41,307)
Stock compensation expense, shares 154,165      
Ending balance, value at Sep. 30, 2021 $ 19,999 13,213,795 (10,122,768) 3,111,026
Shares, Outstanding, Beginning Balance at Sep. 30, 2021 19,998,683      
Beginning balance, value at Jun. 30, 2021 $ 19,641 13,169,363 (10,040,370) 3,148,634
Shares, Outstanding, Beginning Balance at Jun. 30, 2021 19,640,888      
Net loss       (4,158,061)
Ending balance, value at Dec. 31, 2021 $ 19,999 17,084,730 (14,152,622) 2,952,107
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 19,998,683      
Beginning balance, value at Sep. 30, 2021 $ 19,999 13,213,795 (10,122,768) 3,111,026
Shares, Outstanding, Beginning Balance at Sep. 30, 2021 19,998,683      
Stock compensation expense 3,870,935 3,870,935
Net loss (4,029,854) (4,029,854)
Ending balance, value at Dec. 31, 2021 $ 19,999 17,084,730 (14,152,622) 2,952,107
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 19,998,683      
Beginning balance, value at Jun. 30, 2022 $ 21,978 18,394,641 (15,799,395) 2,617,224
Shares, Outstanding, Beginning Balance at Jun. 30, 2022 21,977,251      
Issuance of common stock in underwritten public offering $ 1,121 3,779,284 3,780,405
Issuance of common stock in underwritten public offering, shares 1,121,250      
Issuance of common stock for conversion of debt and accrued interest $ 9,672 1,169,614 1,179,286
Issuance of common stock for conversion of debt and accrued interest, shares 9,671,867      
Stock compensation expense 591,816 591,816
Net loss (698,586) (698,586)
Ending balance, value at Sep. 30, 2022 $ 32,771 23,935,355 (16,497,981) 7,470,145
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 32,770,368      
Beginning balance, value at Jun. 30, 2022 $ 21,978 18,394,641 (15,799,395) 2,617,224
Shares, Outstanding, Beginning Balance at Jun. 30, 2022 21,977,251      
Net loss       (1,686,115)
Ending balance, value at Dec. 31, 2022 $ 32,846 24,654,575 (17,485,510) 7,201,911
Shares, Outstanding, Beginning Balance at Dec. 31, 2022 32,845,368      
Beginning balance, value at Sep. 30, 2022 $ 32,771 23,935,355 (16,497,981) 7,470,145
Shares, Outstanding, Beginning Balance at Sep. 30, 2022 32,770,368      
Stock compensation expense $ 75 719,220 719,295
Net loss (987,529) (987,529)
Stock compensation expense, shares 75,000      
Ending balance, value at Dec. 31, 2022 $ 32,846 $ 24,654,575 $ (17,485,510) $ 7,201,911
Shares, Outstanding, Beginning Balance at Dec. 31, 2022 32,845,368      
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:    
Net loss $ (1,686,115) $ (4,158,061)
Adjustments to reconcile net loss to net cash used in operations:    
Stock compensation expense 1,311,111 4,001,558
Bad debt expense 80,000 0
Changes in current assets and liabilities    
Accounts receivable (573,435) (325,004)
Inventory 499,272 126,609
Prepaid insurance and other current assets (37,471) (72,617)
Accounts payable (175,990) (43,160)
Accrued expenses (105,465) 197
Other, net 0 (5,445)
Net cash flows used in operating activities (688,093) (475,923)
Cash flows from financing activities:    
Underwritten public offering of common stock 3,780,405 0
Proceeds from convertible notes payable 0 1,068,000
Net cash flows provided by financing activities 3,780,405 1,068,000
Net increase in cash and cash equivalents 3,092,312 592,077
Cash and cash equivalents at beginning of period 330,385 425,681
Cash and cash equivalents at end of period 3,422,697 1,017,758
Supplemental disclosures of cash flow information    
Cash paid for interest 0 0
Cash paid for income taxes 0 0
Supplemental non-cash financing activities    
Conversion of convertible debt and accrued interest into common stock 1,179,286 1,283
Adjustment of debt discount related to adoption of new accounting principle $ 0 $ 87,116
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Summary of Significant Accounting Policies
6 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Business and Summary of Significant Accounting Policies

(1) Business and Summary of Significant Accounting Policies

 

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of December 31, 2022, the results of its operations for the three and six month periods ended December 31, 2022 and 2021, the changes in its stockholders’ equity for the six month periods ended December 31, 2022 and 2021, and cash flows for the six month periods ended December 31, 2022 and 2021. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.

 

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. The amount in excess of the FDIC insurance at December 31, 2022 was $3,172,697.

 

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of December 31, 2022 and June 30, 2022:

 

Schedule of inventory  December 31,
2022
   June 30,
2022
 
Raw materials  $1,676,141   $1,844,049 
Work in process   62,795    22,768 
Finished goods       371,391 
           
Total  $1,738,936   $2,238,208 

  

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of December 31, 2022 and June 30, 2022.

 

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 27%, 19% and 12% of the Company’s revenues in the six months ended December 31, 2022, however, no other dealers accounted for more than 10% of the revenues in such period. Two of those same two dealers represented an aggregate of approximately 61% of the Company’s accounts receivable as of December 31, 2022 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of December 31, 2022. Four dealers represented approximately 17%, 15%, 13% and 12% of the Company’s revenues in the six months ended December 31, 2021. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the six months ended December 31, 2022 and 2021 is provided.

 

Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of December 31, 2022 and June 30, 2022, our allowance for doubtful accounts was $80,000 and zero, respectively.

 

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2022, the Company had total outstanding common stock equivalents of 1,529,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) 350,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 3).

 

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. 

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. 

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.

 

At December 31, 2022 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. With the proceeds of this equity offering, we anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

 

XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Notes Payable
6 Months Ended
Dec. 31, 2022
Debt Disclosure [Abstract]  
Notes Payable

(2)        Notes Payable

 

In conjunction with the closing of our underwritten public offering in August 2022 (see Note 3), all holders of the Company’s two outstanding series of convertible notes payable, which were originally issued to various accredited investors in May 2018 and October 2021, agreed to convert their debt into a total of 9,671,867 shares of our common stock at the respective conversion rates. Each of these two series of our converted notes payable is further described below.

 

In May 2018, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $104,688. Each unsecured note originally bore interest at a rate of 12% per annum, which was later reduced by mutual agreement to 3.99% per annum in May 2019. Subsequently, the holders of certain of these notes elected to convert or exchange certain portions of their convertible notes payable into shares of our common stock, based upon the stated conversion rate of $0.0063 per share. As of the closing of our underwritten public offering in August 2022, the holders of the remaining balance of such unconverted notes in the total amount of $59,251, including accrued interest, agreed to convert their debt into a total of 9,404,867 shares of our common stock at the stated conversion rate of $0.0063 per share.

 

In October 2021, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $1,068,000. Each unsecured note bore interest at a rate of 6% per annum. As of the closing of our underwritten public offering in August 2022, pursuant to the terms of such convertible notes, the notes were automatically converted into a total of 267,000 shares of our common stock at the stated conversion rate of $4.00 of principal per share.

 

XML 21 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Equity
6 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Equity

(3)        Equity

 

Common Stock – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $4.00 per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.

 

In the underwritten public offering, a total of 1,121,250 Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $4.00 per Unit. The gross proceeds of the offering were $4,485,000 and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $3,780,000. The Company also granted the underwriter non-tradeable warrants to purchase a total of 58,500 shares of common stock at an exercise price of $4.40 per share for a period of five years.

 

 

 

 

In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $59,251, including accrued interest, converted their debt into a total of 9,404,867 shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $1,068,000 converted their debt into a total of 267,000 shares of common stock at the stated conversion rate (see Note 2).

 

In the six months ended December 31, 2021, the holders of the 2018 convertible notes payable having total principal and accrued interest balances in the aggregate amount of $1,283 elected to convert their notes. Based upon the stated conversion price of $0.0063 per share, these holders converted their notes payable into a total of 203,630 shares of common stock (see Note 2).

 

Warrants – The Warrants for a total of 1,179,750 shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.

 

The following table presents activity with respect to the Company’s warrants for the six months ended December 31, 2022:

 

Schedule of warrants activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at July 1, 2022                  
Warrants issued to Public Investors   1,121,250    4.00           
Warrants issued to Underwriters   58,500    4.40           
Outstanding at December 31, 2022   1,179,750    4.02    4.5   $ 
                     
Exercisable at December 31, 2022   1,179,750    4.02    4.5   $ 

 

These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.

 

Stock Compensation Expense – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of January 1, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to the CEO as of that date.

 

In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to the CFO as of that date.

 

Based upon the Company’s assessment of the probability of the CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, the Company has calculated the grant date value of such awards and is amortizing it as stock compensation expense over the underlying performance periods. The Company has recognized stock compensation expense applicable to such RSU awards in the six months ended December 31, 2022 in the amount of $1,159,882.

 

In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of December 31, 2022, we booked an initial accrual of $97,500 of compensation expense (of which $87,750 will be settled through the issuance of shares) for our three independent directors under this plan. At the same time, we also granted 26,000 shares, with a grant date value of $97,500, to various advisors pursuant to annual contracts for their services. In the six months ended December 31, 2022, we recognized total non-cash stock compensation expense of $1,311,111 as follows: (i) $1,159,882 for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $87,750 for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $48,750 for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $14,729 for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2022 (see Note 4). There was a total of 75,000 shares of common stock that were issued to three grantees, a director and two advisory board members, in the six months ended December 31, 2022, which were previously expensed in the year ended June 30, 2022.

 

In the six months ended December 31, 2021, the Company recognized non-cash stock compensation expense in the total amount of $4,001,558 as follows: (i) $3,505,000 for the fair value of 500,000 incentive shares earned as of December 31, 2021 by a company controlled by the Company’s CEO under a previous compensation plan (which were not issued until early 2022); (ii) $175,250 for the fair value of 25,000 bonus shares earned as of December 31, 2021 by an outside attorney (which were not issued until early 2022); (iii) $157,746 for the amortized value of 50,000 shares granted to an attorney and a consultant pursuant to one year service agreements in mid 2021; (iv) $103,500 for the amortized value of 50,000 shares attributable to a new independent director in early 2021; and (v) $60,062 for the fair value of 8,568 incentive shares earned by a wholesale dealer as of December 31, 2021 (see Note 4). There was a total of 154,165 shares of common stock that were issued to various grantees, primarily advisors, attorneys and consultants, in the six months ended December 31, 2021.

 

Other Matters – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to 2,500,000 shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of December 31, 2022, the Company has made awards totaling 450,000 shares for the RSUs granted to two executives, as noted above, under the Plan.

 

XML 22 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Commitments and Contingencies
6 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

(4)       Commitments and Contingencies

 

Effective January 1, 2021, the Company secured new corporate and manufacturing office space under a sublease agreement with its contract manufacturer. Under the terms of the sublease agreement, the Company is required to make rental payments of $10,350 per month during the initial one-year term of the agreement. The sublease agreement is renewable upon mutual agreement of both parties for up to four additional years at a modest increase in the monthly rent, however, the Company is under is no obligation to renew it. Management has determined that the exercise of the renewal option is not reasonably certain and, as such, the Company has accounted for it as a short-term lease under ASC 842, Leases. Effective January 1, 2023, the Company elected to renew the agreement for another one year period.

 

As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums.

 

From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.

 

XML 23 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Subsequent Events
6 Months Ended
Dec. 31, 2022
Subsequent Events [Abstract]  
Subsequent Events

(5)        Subsequent Events

 

As of January 1, 2023, we issued a total of 300,000 shares of common stock to our two executive officers in recognition of each officer having achieved Milestone 1 under their respective Board approved RSU awards (see Note 3).

 

XML 24 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Summary of Significant Accounting Policies (Policies)
6 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business

Description of Business – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).

 

Interim Financial Information

Interim Financial Information – The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of December 31, 2022, the results of its operations for the three and six month periods ended December 31, 2022 and 2021, the changes in its stockholders’ equity for the six month periods ended December 31, 2022 and 2021, and cash flows for the six month periods ended December 31, 2022 and 2021. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.

 

Cash and Cash Equivalents

Cash and Cash Equivalents – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. The amount in excess of the FDIC insurance at December 31, 2022 was $3,172,697.

 

Inventory

Inventory – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of December 31, 2022 and June 30, 2022:

 

Schedule of inventory  December 31,
2022
   June 30,
2022
 
Raw materials  $1,676,141   $1,844,049 
Work in process   62,795    22,768 
Finished goods       371,391 
           
Total  $1,738,936   $2,238,208 

  

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. No inventory reserve was required as of December 31, 2022 and June 30, 2022.

 

Revenue Recognition

Revenue Recognition – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:

 

·Identification of the contract with a customer
·Identification of the performance obligations in the contract
·Determination of the transaction price
·Allocation of the transaction price to the performance obligations in the contract
·Recognition of revenue when, or as, the Company satisfies a performance obligation

 

The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately 27%, 19% and 12% of the Company’s revenues in the six months ended December 31, 2022, however, no other dealers accounted for more than 10% of the revenues in such period. Two of those same two dealers represented an aggregate of approximately 61% of the Company’s accounts receivable as of December 31, 2022 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of December 31, 2022. Four dealers represented approximately 17%, 15%, 13% and 12% of the Company’s revenues in the six months ended December 31, 2021. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the six months ended December 31, 2022 and 2021 is provided.

 

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of December 31, 2022 and June 30, 2022, our allowance for doubtful accounts was $80,000 and zero, respectively.

 

Income Taxes

Income Taxes – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

 

The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.

 

Stock Compensation Expense

Stock Compensation Expense – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.

 

Loss Per Common Share

Loss Per Common Share – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2022, the Company had total outstanding common stock equivalents of 1,529,750 shares as follows: (i) 1,121,250 shares related to warrants issued to investors in the public offering completed in August 2022; (ii) 58,500 shares related to warrants issued to the underwriters in that same offering; and (iii) 350,000 shares related to restricted stock units granted to two officers in March 2022 (see Note 3).

 

Research and Development Costs

Research and Development Costs – Research and development costs are expensed as incurred.

 

Use of Estimates

Use of Estimates – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.

 

Related Parties

Related Parties - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.

 

Fair Value Measurements and Financial Instruments

Fair Value Measurements and Financial Instruments - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below: 

 

Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. 

 

Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. 

 

Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.

 

At December 31, 2022 and June 30, 2022, the Company did not have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.

 

Liquidity

Liquidity – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. With the proceeds of this equity offering, we anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.

 

XML 25 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of inventory
Schedule of inventory  December 31,
2022
   June 30,
2022
 
Raw materials  $1,676,141   $1,844,049 
Work in process   62,795    22,768 
Finished goods       371,391 
           
Total  $1,738,936   $2,238,208 
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Tables)
6 Months Ended
Dec. 31, 2022
Equity [Abstract]  
Schedule of warrants activity
Schedule of warrants activity  Number   Wtd. Avg.   Wtd. Avg.   Aggregate 
   of   Exercise   Remaining   Intrinsic 
   Shares   Price   Term (Yrs.)   Value 
Outstanding at July 1, 2022                  
Warrants issued to Public Investors   1,121,250    4.00           
Warrants issued to Underwriters   58,500    4.40           
Outstanding at December 31, 2022   1,179,750    4.02    4.5   $ 
                     
Exercisable at December 31, 2022   1,179,750    4.02    4.5   $ 
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Summary of Significant Accounting Policies (Details Inventory) - USD ($)
6 Months Ended
Dec. 31, 2022
Jun. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Raw materials $ 1,676,141 $ 1,844,049
Work in process 62,795 22,768
Finished goods 0 371,391
Total 1,738,936 $ 2,238,208
Allowance for doubtful accounts $ 80,000  
Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 1,529,750  
Warrants [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 1,121,250  
Warrants Underwriters [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 58,500  
Restricted Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 350,000  
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Product Information [Line Items]    
Cash, Uninsured Amount $ 3,172,697  
Inventory Valuation Reserves 0  
Liabilities, Fair Value Disclosure 0  
Assets, Fair Value Disclosure $ 0  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | One Dealer [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 27.00% 17.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Another Dealer [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 19.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Thrid Dealer [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 12.00%  
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer Two [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage   15.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer Three [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage   13.00%
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Dealer Four [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage   12.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Two Dealers [Member]    
Product Information [Line Items]    
Concentration Risk, Percentage 61.00%  
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Notes Payable (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended
Aug. 31, 2022
Oct. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Debt Instrument [Line Items]        
Conversion of Stock, Amount Converted $ 59,251      
Shares converted 9,404,867     203,630
Conversion price $ 0.0063      
Proceeds from Convertible Debt     $ 0 $ 1,068,000
Convertible Debt [Member]        
Debt Instrument [Line Items]        
Conversion of Stock, Amount Converted     $ 59,251  
Shares converted   267,000 9,404,867  
Conversion price   $ 4.00    
Proceeds from Convertible Debt   $ 1,068,000    
Debt Instrument, Interest Rate, Stated Percentage   6.00%    
Common Stock [Member]        
Debt Instrument [Line Items]        
Number of shares converted 9,671,867      
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Details - Warrant activity)
6 Months Ended
Dec. 31, 2022
USD ($)
$ / shares
shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
Class of Warrant or Right, Outstanding | shares 0
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 0
Class of Warrant or Right, Outstanding | shares 1,179,750
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares $ 4.02
Warrants and Rights Outstanding, Term 4 years 6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding | $ $ 0
Warrant exercisable, shares | shares 1,179,750
Warrants exercisable, weighted average exercise price | $ / shares $ 4.02
Warrants term, exercisable 4 years 6 months
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable-0] | $ $ 0
Public Investors [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
[custom:WarrantsIssuedShares] | shares 1,121,250
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 4.00
Underwriters [Member]  
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]  
[custom:WarrantsIssuedShares] | shares 58,500
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 4.40
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Details Narrative) - USD ($)
1 Months Ended 5 Months Ended 6 Months Ended 47 Months Ended
Aug. 31, 2022
Oct. 31, 2021
Dec. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Jun. 30, 2022
Feb. 28, 2019
Subsidiary, Sale of Stock [Line Items]                
Exercise price $ 4.00   $ 4.02 $ 4.02   $ 4.02 $ 0  
Proceeds from Issuance Initial Public Offering       $ 3,780,405 $ 0      
Amounts converted $ 59,251              
Shares converted 9,404,867       203,630      
Proceeds from Convertible Debt       0 $ 1,068,000      
Debt Conversion, Converted Instrument, Amount         1,283      
Share-Based Payment Arrangement, Noncash Expense       1,311,111 4,001,558      
2019 Stock Option Plan [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized               2,500,000
Amortized Value of RSUs Granted [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense       1,159,882        
Amortized Value Of New Compensation Plan [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense       87,750        
Amortized Value Of Shares Granted To Various Advisors [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense       48,750        
Fair Value Of Incentive Shares [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense       14,729 3,505,000      
Fair Value Of Bonus Shares Earned [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense         175,250      
Amortized Value Of Shares Granted To Attorney [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense         157,746      
Amortized Value Of Shares To New Independent Director [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense         103,500      
Fair Value Of Incentive Shares Wholesale Dealer [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Payment Arrangement, Noncash Expense         $ 60,062      
Three Independent Directors [Member]                
Subsidiary, Sale of Stock [Line Items]                
Accrued compensation expenses     $ 97,500 $ 97,500   $ 97,500    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period     26,000          
Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture     $ 97,500          
Three Grantees [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period       75,000        
Two Executives [Member] | Restricted Stock Units (RSUs) [Member]                
Subsidiary, Sale of Stock [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period           450,000    
Convertible Debt [Member]                
Subsidiary, Sale of Stock [Line Items]                
Amounts converted       $ 59,251        
Shares converted   267,000   9,404,867        
Proceeds from Convertible Debt   $ 1,068,000            
Convertible Debt 1 [Member]                
Subsidiary, Sale of Stock [Line Items]                
Shares converted       267,000        
Proceeds from Convertible Debt       $ 1,068,000        
Warrant [Member]                
Subsidiary, Sale of Stock [Line Items]                
Exercise price     $ 4.40 $ 4.40   $ 4.40    
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant     58,500 58,500   58,500    
Number of shares exercisable     1,179,750 1,179,750   1,179,750    
Public Offering [Member]                
Subsidiary, Sale of Stock [Line Items]                
Proceeds from Issuance or Sale of Equity       $ 3,780,000        
IPO [Member]                
Subsidiary, Sale of Stock [Line Items]                
Sale of Stock, Number of Shares Issued in Transaction       1,121,250        
Sale of Stock, Price Per Share     $ 4.00 $ 4.00   $ 4.00    
Proceeds from Issuance Initial Public Offering       $ 4,485,000        
XML 32 neovolta_i10q-123122_htm.xml IDEA: XBRL DOCUMENT 0001748137 2022-07-01 2022-12-31 0001748137 NEOV:CommonStockParValue0.001PerShareMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsEachWarrantExercisableForOneShareOfCommonStockMember 2022-07-01 2022-12-31 0001748137 2023-02-10 0001748137 2022-12-31 0001748137 2022-06-30 0001748137 2022-10-01 2022-12-31 0001748137 2021-10-01 2021-12-31 0001748137 2021-07-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001748137 us-gaap:RetainedEarningsMember 2022-06-30 0001748137 us-gaap:CommonStockMember 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-09-30 0001748137 2022-09-30 0001748137 us-gaap:CommonStockMember 2021-06-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001748137 us-gaap:RetainedEarningsMember 2021-06-30 0001748137 2021-06-30 0001748137 us-gaap:CommonStockMember 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-09-30 0001748137 2021-09-30 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001748137 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001748137 2022-07-01 2022-09-30 0001748137 us-gaap:CommonStockMember 2022-10-01 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-10-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001748137 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001748137 2021-07-01 2021-09-30 0001748137 us-gaap:CommonStockMember 2021-10-01 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-10-01 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-10-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001748137 us-gaap:RetainedEarningsMember 2022-12-31 0001748137 us-gaap:CommonStockMember 2021-12-31 0001748137 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001748137 us-gaap:RetainedEarningsMember 2021-12-31 0001748137 2021-12-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-12-31 0001748137 NEOV:AnotherDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-12-31 0001748137 NEOV:ThridDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-12-31 0001748137 NEOV:TwoDealersMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-12-31 0001748137 NEOV:OneDealerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-12-31 0001748137 NEOV:DealerTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-12-31 0001748137 NEOV:DealerThreeMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-12-31 0001748137 NEOV:DealerFourMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-07-01 2021-12-31 0001748137 us-gaap:CommonStockMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsMember 2022-07-01 2022-12-31 0001748137 NEOV:WarrantsUnderwritersMember 2022-07-01 2022-12-31 0001748137 us-gaap:RestrictedStockMember 2022-07-01 2022-12-31 0001748137 us-gaap:CommonStockMember 2022-08-01 2022-08-31 0001748137 2022-08-01 2022-08-31 0001748137 2022-08-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-01 2021-10-31 0001748137 us-gaap:ConvertibleDebtMember 2021-10-31 0001748137 us-gaap:IPOMember 2022-07-01 2022-12-31 0001748137 us-gaap:IPOMember 2022-12-31 0001748137 NEOV:PublicOfferingMember 2022-07-01 2022-12-31 0001748137 us-gaap:WarrantMember 2022-12-31 0001748137 us-gaap:ConvertibleDebtMember 2022-07-01 2022-12-31 0001748137 NEOV:ConvertibleDebt1Member 2022-07-01 2022-12-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2022-12-31 0001748137 NEOV:ThreeIndependentDirectorsMember 2022-08-01 2022-12-31 0001748137 NEOV:AmortizedValueOfRSUsGrantedMember 2022-07-01 2022-12-31 0001748137 NEOV:AmortizedValueOfNewCompensationPlanMember 2022-07-01 2022-12-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToVariousAdvisorsMember 2022-07-01 2022-12-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2022-07-01 2022-12-31 0001748137 NEOV:ThreeGranteesMember 2022-07-01 2022-12-31 0001748137 NEOV:FairValueOfIncentiveSharesMember 2021-07-01 2021-12-31 0001748137 NEOV:FairValueOfBonusSharesEarnedMember 2021-07-01 2021-12-31 0001748137 NEOV:AmortizedValueOfSharesGrantedToAttorneyMember 2021-07-01 2021-12-31 0001748137 NEOV:AmortizedValueOfSharesToNewIndependentDirectorMember 2021-07-01 2021-12-31 0001748137 NEOV:FairValueOfIncentiveSharesWholesaleDealerMember 2021-07-01 2021-12-31 0001748137 NEOV:StockOptionPlan2019Member 2019-02-28 0001748137 NEOV:TwoExecutivesMember us-gaap:RestrictedStockUnitsRSUMember 2019-02-01 2022-12-31 0001748137 NEOV:PublicInvestorsMember 2022-07-01 2022-12-31 0001748137 NEOV:UnderwritersMember 2022-07-01 2022-12-31 iso4217:USD shares iso4217:USD shares pure 0001748137 false --06-30 2023 Q2 No No 10-Q true 2022-12-31 false 001-41447 NeoVolta, Inc. NV 82-5299263 13651 Danielson Street Suite A Poway CA 92064 (800) 364-5464 Common Stock, par value $0.001 per share NEOV NASDAQ Warrants, each warrant exercisable for one share of common stock NEOVW NASDAQ Non-accelerated Filer true true false false 33145368 3422697 330385 1811173 1317738 1738936 2238208 276472 239001 7249278 4125332 7249278 4125332 29610 205600 0 53436 17757 127356 0 1068000 47367 1454392 0 53716 47367 1508108 0.001 0.001 100000000 100000000 32845368 32845368 21977251 21977251 32846 21978 24654575 18394641 -17485510 -15799395 7201911 2617224 7249278 4125332 567105 1035127 473159 861706 93946 173421 1073729 4137495 7746 62250 1081475 4199745 -987529 -4026324 -0 3530 0 -3530 -987529 -4029854 32822542 32822542 19998683 19998683 -0.03 -0.03 -0.20 -0.20 2104941 2634731 1765119 2222700 339822 412031 1993157 4494053 28646 66503 2021803 4560556 -1681981 -4148525 4134 9536 -4134 -9536 -1686115 -4158061 30916212 30916212 19982352 19982352 -0.05 -0.05 -0.21 -0.21 21977251 21978 18394641 -15799395 2617224 1121250 1121 3779284 3780405 9671867 9672 1169614 1179286 591816 591816 -698586 -698586 32770368 32771 23935355 -16497981 7470145 75000 75 719220 719295 -987529 -987529 32845368 32846 24654575 -17485510 7201911 19640888 19641 13169363 -10040370 3148634 203630 204 1079 1283 154165 154 130469 130623 -87116 45809 -41307 -128207 -128207 19998683 19999 13213795 -10122768 3111026 3870935 3870935 -4029854 -4029854 19998683 19999 17084730 -14152622 2952107 -1686115 -4158061 1311111 4001558 80000 0 573435 325004 -499272 -126609 37471 72617 -175990 -43160 -105465 197 0 -5445 -688093 -475923 3780405 0 0 1068000 3780405 1068000 3092312 592077 330385 425681 3422697 1017758 0 0 0 0 1179286 1283 0 87116 <p id="xdx_801_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zrXkD6iwOulh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(<span style="font-size: 10pt">1) <span id="xdx_82F_zzsF29AhmKR1">Business and Summary of Significant Accounting Policies</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_ecustom--DescriptionOfBusinessPolicyTextBlock_zM6DLZQAqgpj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zqb2vXJmT94l">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zPBF9lAp5TU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zOonkLCusH58">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of December 31, 2022, the results of its operations for the three and six month periods ended December 31, 2022 and 2021, the changes in its stockholders’ equity for the six month periods ended December 31, 2022 and 2021, and cash flows for the six month periods ended December 31, 2022 and 2021. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zDm141eHsPNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zLeLY311Ies9">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. The amount in excess of the FDIC insurance at December 31, 2022 was $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20221231_zx7ZQqgm01hh" title="Cash, Uninsured Amount">3,172,697</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zEuZyXMj3Fjh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_z6G9bJK3MR9i">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of December 31, 2022 and June 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQeH8SbVGoJa" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><b style="display: none"><span id="xdx_8B6_zm4HV8I90fQh">Schedule of inventory</span></b></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20221231_zxlNF3b18Zcb" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_494_20220630_zIo2mj11hXGd" style="border-bottom: Black 1pt solid; text-align: center"><b>June 30,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzRTK_zH0LTAlQn2zk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 46%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,676,141</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzRTK_zPeJINKgmZie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINzRTK_zskC67p1Dwze" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: left">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzRTK_zgJLai8tCBch" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,738,936</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. <span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_pp0p0_do_c20221231_zJyoGb6zgYnh" title="Inventory Valuation Reserves">No</span> inventory reserve was required as of December 31, 2022 and June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zskx15jj5QT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_z29k4GvshgUj">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zOGcvMDb9z0c" title="Concentration Risk, Percentage">27</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherDealerMember_zlSbSZSa3FBa" title="Concentration Risk, Percentage">19</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThridDealerMember_zbvyldB3FBif" title="Concentration Risk, Percentage">12</span>% of the Company’s revenues in the six months ended December 31, 2022, however, no other dealers accounted for more than 10% of the revenues in such period. Two of those same two dealers represented an aggregate of approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_z4aefEHLZ4Dl" title="Concentration Risk, Percentage">61</span>% of the Company’s accounts receivable as of December 31, 2022 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of December 31, 2022. Four dealers represented approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zncNwRXI2zz3" title="Concentration Risk, Percentage">17</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zIJCFUWKE689" title="Concentration Risk, Percentage">15</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zhrjc1Plpylf" title="Concentration Risk, Percentage">13</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerFourMember_zRmseWEcfMD5" title="Concentration Risk, Percentage">12</span>% of the Company’s revenues in the six months ended December 31, 2021. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the six months ended December 31, 2022 and 2021 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_eus-gaap--RevenueRecognitionAllowances_zcbas5tfZNyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zPObxJX0rxFh">Allowance for Doubtful Accounts</span></i> – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of December 31, 2022 and June 30, 2022, our allowance for doubtful accounts was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20221231_zJBdJjAcX2t1" title="Allowance for doubtful accounts">80,000</span> and zero, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zSOU1n89Hs74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zGE6hDgE5xVf">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zV9BhI2jWvS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zd6sSBCsdpTe">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zRTpW9A9mkY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zcykrTNZHrdf">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2022, the Company had total outstanding common stock equivalents of <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zmGbFhoOsbra" title="Antidilutive shares">1,529,750</span> shares as follows: (i) <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zsCvDBQmvnW5" title="Antidilutive shares">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsUnderwritersMember_zxsnQfSsTVbg" title="Antidilutive shares">58,500</span> shares related to warrants issued to the underwriters in that same offering; and (iii) <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zjCk6y09DOL2" title="Antidilutive shares">350,000</span> shares related to restricted stock units granted to two officers in March 2022 (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zgYYYyYiVqfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_868_zrAXaIbiAzr5">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zX0cSlcYIcN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zHkz2leWR0Ud">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_ecustom--RelatedPartiesPolicyTextBlock_zdantjefuXCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zu0UBF0ObiT4">Related Parties</span></i> - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i> </i></p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zqlq5pIDv5Yg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i><span id="xdx_86E_z1CfjD5gSK4">Fair Value Measurements and Financial Instruments</span></i> - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). <span style="background-color: white">The three levels of the fair value hierarchy are described below: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2022 and June 30, 2022, the Company did <span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_do_c20221231_zJIPkPgqzAt" title="Liabilities, Fair Value Disclosure"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_do_c20221231_zJ1UiHdwEg1c" title="Assets, Fair Value Disclosure">no</span></span>t have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zODOkOTxAqO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_z3OdHhXvhJ88">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zMMTITigz322" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zLmAwggvHjuc">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. With the proceeds of this equity offering, we anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84B_ecustom--DescriptionOfBusinessPolicyTextBlock_zM6DLZQAqgpj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86A_zqb2vXJmT94l">Description of Business</span></i> – NeoVolta Inc. (“we”, “our” or the “Company”) is a Nevada corporation, which was formed on March 5, 2018. The Company is a designer, seller and manufacturer of Energy Storage Systems (ESS) which can store and use energy via batteries and an inverter at residential and commercial sites. The Company sells its proprietary ESS units through wholesale customers, primarily in California, and in an expanding number of other states. In August 2022, the Company completed an underwritten public offering of its equity securities resulting in its common stock and warrants becoming listed on a national exchange (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_849_ecustom--InterimFinancialInformationPolicyTextBlock_zPBF9lAp5TU8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zOonkLCusH58">Interim Financial Information</span> </i>– The Company has prepared the accompanying financial statements, without audit, in accordance with accounting principles generally accepted in the Unites States of America for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). In the opinion of management, these financial statements contain all adjustments, consisting only of normal recurring adjustments, necessary to fairly state the Company’s financial position as of December 31, 2022, the results of its operations for the three and six month periods ended December 31, 2022 and 2021, the changes in its stockholders’ equity for the six month periods ended December 31, 2022 and 2021, and cash flows for the six month periods ended December 31, 2022 and 2021. The balance sheet as of June 30, 2022 has been derived from the Company’s June 30, 2022 financial statements that were audited by an independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with our Annual Report on Form 10-K for the year ended June 30, 2022, as filed with the SEC on September 27, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_843_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zDm141eHsPNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_860_zLeLY311Ies9">Cash and Cash Equivalents</span></i> – The Company considers all highly liquid accounts with original maturities of three months or less at the date of acquisition to be cash equivalents. Periodically, the Company may carry cash balances at financial institutions in excess of the federally insured limit of $250,000. The amount in excess of the FDIC insurance at December 31, 2022 was $<span id="xdx_905_eus-gaap--CashUninsuredAmount_iI_pp0p0_c20221231_zx7ZQqgm01hh" title="Cash, Uninsured Amount">3,172,697</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 3172697 <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zEuZyXMj3Fjh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_z6G9bJK3MR9i">Inventory</span></i> – Inventory consists of batteries and inverters purchased from Asian suppliers and delivered to a location near the Company’s offices, for assembly into ESS units. Inventory is stated at the lower of cost or net realizable value, cost being determined using the first-in, first out (FIFO) method. The following table presents the components of inventory as of December 31, 2022 and June 30, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQeH8SbVGoJa" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><b style="display: none"><span id="xdx_8B6_zm4HV8I90fQh">Schedule of inventory</span></b></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20221231_zxlNF3b18Zcb" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_494_20220630_zIo2mj11hXGd" style="border-bottom: Black 1pt solid; text-align: center"><b>June 30,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzRTK_zH0LTAlQn2zk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 46%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,676,141</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzRTK_zPeJINKgmZie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINzRTK_zskC67p1Dwze" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: left">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzRTK_zgJLai8tCBch" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,738,936</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">  </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. Inventory write-downs are charged to cost of goods sold. <span id="xdx_901_eus-gaap--InventoryValuationReserves_iI_pp0p0_do_c20221231_zJyoGb6zgYnh" title="Inventory Valuation Reserves">No</span> inventory reserve was required as of December 31, 2022 and June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <table cellpadding="0" cellspacing="0" id="xdx_887_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zQeH8SbVGoJa" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto" summary="xdx: Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"><b style="display: none"><span id="xdx_8B6_zm4HV8I90fQh">Schedule of inventory</span></b></td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20221231_zxlNF3b18Zcb" style="border-bottom: Black 1pt solid; text-align: center"><b>December 31,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2" id="xdx_494_20220630_zIo2mj11hXGd" style="border-bottom: Black 1pt solid; text-align: center"><b>June 30,<br/> 2022</b></td><td style="padding-bottom: 1pt"><b> </b></td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterials_iI_pp0p0_maINzRTK_zH0LTAlQn2zk" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 46%; text-align: left">Raw materials</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,676,141</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">1,844,049</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maINzRTK_zPeJINKgmZie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Work in process</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">62,795</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,768</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_pp0p0_d0_maINzRTK_zskC67p1Dwze" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-bottom: 1pt; text-align: left">Finished goods</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">–</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">371,391</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzRTK_zgJLai8tCBch" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="padding-left: 20pt; padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,738,936</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,238,208</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1676141 1844049 62795 22768 0 371391 1738936 2238208 0 <p id="xdx_84D_eus-gaap--RevenueRecognitionPolicyTextBlock_zskx15jj5QT9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_863_z29k4GvshgUj">Revenue Recognition</span></i> – The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606). Revenues are recognized when control of the promised goods is transferred to the customer in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring those goods or services. Revenue is recognized based on the following five step model:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the contract with a customer</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Identification of the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Determination of the transaction price</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Allocation of the transaction price to the performance obligations in the contract</td></tr> <tr style="vertical-align: top"> <td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">·</span></td><td style="text-align: justify">Recognition of revenue when, or as, the Company satisfies a performance obligation</td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company generates revenues from contracts with customers, consisting of a relatively small number of wholesale dealers and installers, primarily in California. Three such dealers represented approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zOGcvMDb9z0c" title="Concentration Risk, Percentage">27</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--AnotherDealerMember_zlSbSZSa3FBa" title="Concentration Risk, Percentage">19</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--ThridDealerMember_zbvyldB3FBif" title="Concentration Risk, Percentage">12</span>% of the Company’s revenues in the six months ended December 31, 2022, however, no other dealers accounted for more than 10% of the revenues in such period. Two of those same two dealers represented an aggregate of approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_c20220701__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--TwoDealersMember_z4aefEHLZ4Dl" title="Concentration Risk, Percentage">61</span>% of the Company’s accounts receivable as of December 31, 2022 (net of allowance), however, no other dealers accounted for more than 10% of the accounts receivable as of December 31, 2022. Four dealers represented approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneDealerMember_zncNwRXI2zz3" title="Concentration Risk, Percentage">17</span>%, <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerTwoMember_zIJCFUWKE689" title="Concentration Risk, Percentage">15</span>%, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerThreeMember_zhrjc1Plpylf" title="Concentration Risk, Percentage">13</span>% and <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20210701__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--DealerFourMember_zRmseWEcfMD5" title="Concentration Risk, Percentage">12</span>% of the Company’s revenues in the six months ended December 31, 2021. Since all of the Company’s revenue is currently generated from the sales of similar products, no further disaggregation of revenue information for the six months ended December 31, 2022 and 2021 is provided.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.27 0.19 0.12 0.61 0.17 0.15 0.13 0.12 <p id="xdx_84B_eus-gaap--RevenueRecognitionAllowances_zcbas5tfZNyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_869_zPObxJX0rxFh">Allowance for Doubtful Accounts</span></i> – The Company recognizes an allowance for doubtful accounts whenever a loss is expected to be incurred in the realization of a customer’s account. As of December 31, 2022 and June 30, 2022, our allowance for doubtful accounts was $<span id="xdx_904_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_do_c20221231_zJBdJjAcX2t1" title="Allowance for doubtful accounts">80,000</span> and zero, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 80000 <p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_zSOU1n89Hs74" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_862_zGE6hDgE5xVf">Income Taxes</span></i> – The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company accounts for uncertain tax positions in accordance with the provisions of Accounting Standards Codification (“ASC”) 740-10 which prescribes a recognition threshold and measurement attribute for financial statement disclosure of tax positions taken, or expected to be taken, on its tax return. The Company evaluates and records any uncertain tax positions based on the amount that management deems is more likely than not to be sustained upon examination and ultimate settlement with the tax authorities in the tax jurisdictions in which it operates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_84D_eus-gaap--CompensationRelatedCostsPolicyTextBlock_zV9BhI2jWvS4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86F_zd6sSBCsdpTe">Stock Compensation Expense</span></i> – Employee and non-employee share-based payment compensation is measured at the grant date, based on the fair value of the award, and is recognized as an expense over the requisite service period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i> </i></p> <p id="xdx_840_eus-gaap--EarningsPerSharePolicyTextBlock_zRTpW9A9mkY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86D_zcykrTNZHrdf">Loss Per Common Share</span></i> – Basic loss per common share is computed by dividing net loss available to common shareholders by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of December 31, 2022, the Company had total outstanding common stock equivalents of <span id="xdx_90F_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--CommonStockMember_zmGbFhoOsbra" title="Antidilutive shares">1,529,750</span> shares as follows: (i) <span id="xdx_90D_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsMember_zsCvDBQmvnW5" title="Antidilutive shares">1,121,250</span> shares related to warrants issued to investors in the public offering completed in August 2022; (ii) <span id="xdx_901_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__custom--WarrantsUnderwritersMember_zxsnQfSsTVbg" title="Antidilutive shares">58,500</span> shares related to warrants issued to the underwriters in that same offering; and (iii) <span id="xdx_90A_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20220701__20221231__us-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--RestrictedStockMember_zjCk6y09DOL2" title="Antidilutive shares">350,000</span> shares related to restricted stock units granted to two officers in March 2022 (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> 1529750 1121250 58500 350000 <p id="xdx_843_eus-gaap--ResearchAndDevelopmentExpensePolicy_zgYYYyYiVqfk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_868_zrAXaIbiAzr5">Research and Development Costs</span></i> – Research and development costs are expensed as incurred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_841_eus-gaap--UseOfEstimates_zX0cSlcYIcN3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86E_zHkz2leWR0Ud">Use of Estimates</span></i> – Management has made a number of estimates and assumptions in preparing these financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ from those estimates. As a result of the continued spread of the COVID-19 coronavirus since early 2020, economic uncertainties have arisen which could impact business operations, supply chains, energy demand, and commodity prices that are beyond our control. Overall, we have not experienced a material adverse impact to our economic performance or ability to continue our business operations as a result of COVID-19. We continue to monitor COVID-19, but do not believe it will have a material unfavorable impact to our future financial performance at this time.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_848_ecustom--RelatedPartiesPolicyTextBlock_zdantjefuXCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_866_zu0UBF0ObiT4">Related Parties</span></i> - The Company accounts for related party transactions in accordance with ASC 850. A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that it might be prevented from fully pursuing its own separate interests is also a related party.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i> </i></p> <p id="xdx_849_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zqlq5pIDv5Yg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><i><span id="xdx_86E_z1CfjD5gSK4">Fair Value Measurements and Financial Instruments</span></i> - ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). <span style="background-color: white">The three levels of the fair value hierarchy are described below: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Level 1 - Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 2 - Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly, including quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability (e.g., interest rates); and inputs that are derived principally from or corroborated by observable market data by correlation or other means. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="background-color: white">Level 3 - Inputs that are both significant to the fair value measurement and unobservable.  The carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments. These financial instruments include cash and cash equivalents, accounts receivable, accounts payable, and long-term debt. The carrying value of long-term debt approximates fair value since the related rate of interest approximates current market rates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At December 31, 2022 and June 30, 2022, the Company did <span id="xdx_900_eus-gaap--LiabilitiesFairValueDisclosure_iI_do_c20221231_zJIPkPgqzAt" title="Liabilities, Fair Value Disclosure"><span id="xdx_903_eus-gaap--AssetsFairValueDisclosure_iI_do_c20221231_zJ1UiHdwEg1c" title="Assets, Fair Value Disclosure">no</span></span>t have any financial assets or liabilities measured and recorded at fair value on the Company’s balance sheets on a recurring basis.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> 0 0 <p id="xdx_84F_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zODOkOTxAqO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_867_z3OdHhXvhJ88">Recent Accounting Pronouncements</span></i> – From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board, (“FASB”), or other standard setting bodies and adopted by us as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company’s financial position or results of operations upon adoption. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_840_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zMMTITigz322" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i><span id="xdx_86B_zLmAwggvHjuc">Liquidity</span></i> – These financial statements have been prepared on a going concern basis, which assumes the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern has been dependent upon the ability of the Company to obtain necessary equity financing to continue operations and the attainment of profitable operations. As disclosed in Note 3, we completed a public offering of our equity securities in August 2022 that raised total net proceeds of approximately $3,780,000. With the proceeds of this equity offering, we anticipate that we will have sufficient cash resources in order to operate our business for at least the next 12 months from the date these financial statements are issued.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_808_eus-gaap--DebtDisclosureTextBlock_zguwf3JyeMd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(2)        <span id="xdx_829_zuDWGlm0bwBl">Notes Payable</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with the closing of our underwritten public offering in August 2022 (see Note 3), all holders of the Company’s two outstanding series of convertible notes payable, which were originally issued to various accredited investors in May 2018 and October 2021, agreed to convert their debt into a total of <span id="xdx_904_eus-gaap--ConversionOfStockSharesConverted1_c20220801__20220831__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zoh5s3RvAIF8" title="Number of shares converted">9,671,867</span> shares of our common stock at the respective conversion rates. Each of these two series of our converted notes payable is further described below.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In May 2018, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $104,688. Each unsecured note originally bore interest at a rate of 12% per annum, which was later reduced by mutual agreement to 3.99% per annum in May 2019. Subsequently, the holders of certain of these notes elected to convert or exchange certain portions of their convertible notes payable into shares of our common stock, based upon the stated conversion rate of $0.0063 per share. As of the closing of our underwritten public offering in August 2022, the holders of the remaining balance of such unconverted notes in the total amount of $<span id="xdx_906_eus-gaap--ConversionOfStockAmountConverted1_c20220801__20220831_zG6nb2ffTode">59,251</span>, including accrued interest, agreed to convert their debt into a total of <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220801__20220831_zXuXsMGydO2l">9,404,867</span> shares of our common stock at the stated conversion rate of $<span id="xdx_902_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20220831_zKFIDD9y3tfc">0.0063</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In October 2021, we entered into convertible note payable agreements with a group of accredited investors for aggregate proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20211001__20211031__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zmgZuwWT0674" title="Proceeds from Convertible Debt">1,068,000</span>. Each unsecured note bore interest at a rate of <span id="xdx_909_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_dp_c20211031__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zOesyOCBwmUi" title="Debt Instrument, Interest Rate, Stated Percentage">6</span>% per annum. As of the closing of our underwritten public offering in August 2022, pursuant to the terms of such convertible notes, the notes were automatically converted into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20211001__20211031__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zYTTggSdAyEg" title="Shares converted">267,000</span> shares of our common stock at the stated conversion rate of $<span id="xdx_90F_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20211031__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zXMx3R0smgDi" title="Conversion price">4.00</span> of principal per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 9671867 59251 9404867 0.0063 1068000 0.06 267000 4.00 <p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zjh4NEzAgNp5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(3)        <span id="xdx_82E_znmnACoWbT86">Equity</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Common Stock</i> – In August 2022, the Company completed an underwritten public offering of its equity securities in the form of Units with each Unit consisting of one share of common stock and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20220831_z9jQgGmfu2z6" title="Exercise price">4.00</span> per share. The shares of common stock and the Warrants comprising the Units were immediately separated at closing of the offering and each is now independently listed on the NASDAQ Capital Market. Each Warrant became exercisable on the date of issuance and will expire five years from the date of issuance.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the underwritten public offering, a total of <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20220701__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_znA6CSq6IvOb">1,121,250</span> Units, including exercise of the underwriter’s overallotment option, were sold at an offering price to the public of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zYMJWlTcCbzj">4.00</span> per Unit. The gross proceeds of the offering were $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20220701__20221231__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ztV2WSJPp4He">4,485,000</span> and the net proceeds, after deduction of underwriting discounts and other offering costs were approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20220701__20221231__us-gaap--SecuritiesFinancingTransactionAxis__custom--PublicOfferingMember_z5FAvcGwMPn">3,780,000</span>. The Company also granted the underwriter non-tradeable warrants to purchase a total of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zSYE2o9vAH7d">58,500</span> shares of common stock at an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z2RiHAv5X0ib">4.40</span> per share for a period of five years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with the public offering, all holders of the Company’s 2018 convertible notes in the total amount of $<span id="xdx_90A_eus-gaap--ConversionOfStockAmountConverted1_pp0p0_c20220701__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_z5YzYWQFXeCa" title="Amounts converted">59,251</span>, including accrued interest, converted their debt into a total of <span id="xdx_90D_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220701__20221231__us-gaap--LongtermDebtTypeAxis__us-gaap--ConvertibleDebtMember_zwiyXnW6Gs47" title="Shares converted">9,404,867</span> shares of common stock at the stated conversion rate, and all holders of the Company’s 2021 convertible notes in the total amount of $<span id="xdx_902_eus-gaap--ProceedsFromConvertibleDebt_pp0p0_c20220701__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleDebt1Member_zcvWnoLXkHXc" title="Proceeds from Convertible Debt">1,068,000</span> converted their debt into a total of <span id="xdx_907_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20220701__20221231__us-gaap--LongtermDebtTypeAxis__custom--ConvertibleDebt1Member_zSSNx5kiREej" title="Shares converted">267,000</span> shares of common stock at the stated conversion rate (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the six months ended December 31, 2021, the holders of the 2018 convertible notes payable having total principal and accrued interest balances in the aggregate amount of $<span id="xdx_903_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210701__20211231_zzqeSP17Vpo9" title="Debt Conversion, Converted Instrument, Amount">1,283</span> elected to convert their notes. Based upon the stated conversion price of $0.0063 per share, these holders converted their notes payable into a total of <span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210701__20211231_z8uQpuGEhUY6" title="Shares converted">203,630</span> shares of common stock (see Note 2).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Warrants</i> – The Warrants for a total of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iI_c20221231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z6RKEJuMRWv9" title="Number of shares exercisable">1,179,750</span> shares of common stock issued to investors and the underwriters are exercisable at any time after their original issuance and at any time up to the date that is five years after their original issuance, or August 1, 2027. The Warrants may be exercised upon payment of the exercise price in cash on or prior to the expiration date. Under the terms of the Warrant Agreement, we must use our best efforts to maintain the effectiveness of the registration statement and current prospectus relating to common stock issuable upon exercise of the Warrants until the expiration of the Warrants. If we fail to maintain the effectiveness of the registration statement and current prospectus relating to the common stock issuable upon exercise of the Warrants, the holders of the Warrants shall have the right to exercise the Warrants solely via a cashless exercise feature provided for in the Warrants, until such time as there is an effective registration statement and current prospectus.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents activity with respect to the Company’s warrants for the six months ended December 31, 2022:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz89MxzNSZX4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_z9xC1k6gd64g"><b style="display: none">Schedule of warrants activity</b></span></td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Wtd. Avg.</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Wtd. Avg.</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Aggregate</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Remaining</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Intrinsic</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at July 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20220701__20221231_zx3WoCYJ4Mh6" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20220701__20221231_zOm8EV8w3M7h" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left">Warrants issued to Public Investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantsIssuedShares_c20220701__20221231__srt--CounterpartyNameAxis__custom--PublicInvestorsMember_zTpZ3trslnm5" style="width: 10%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220701__20221231__srt--CounterpartyNameAxis__custom--PublicInvestorsMember_zWwO9oyQWnD2" style="width: 10%; text-align: right">4.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants issued to Underwriters</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--WarrantsIssuedShares_c20220701__20221231__srt--CounterpartyNameAxis__custom--UnderwritersMember_zHo17r8683pe" style="border-bottom: Black 1pt solid; text-align: right">58,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220701__20221231__srt--CounterpartyNameAxis__custom--UnderwritersMember_zq4gH3h165pa" style="border-bottom: Black 1pt solid; text-align: right">4.40</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20220701__20221231_z6xsCmvU3rT9" style="border-bottom: Black 2.5pt double; text-align: right">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20220701__20221231_z2jRRmW5uwX7" style="border-bottom: Black 2.5pt double; text-align: right">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231_zLy4gzjIwEMd" style="border-bottom: Black 2.5pt double; text-align: right">4.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20221231_zBpQZL7Hxl3" style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--WarrantsExercisableShares_iI_c20221231_ziqKMAyDhDPd" style="border-bottom: Black 2.5pt double; text-align: right">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--WarrantsExercisableWeightedAverageExercisePrice_iI_c20221231_zYHjQukHXPz1" style="border-bottom: Black 2.5pt double; text-align: right">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtY_c20221231_zA24AKF6Kjx8" style="border-bottom: Black 2.5pt double; text-align: right">4.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20221231_zqJ2sYsdgN3f" style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">These warrants were issued in conjunction with an underwritten public equity offering, therefore, there was no employee or non-employee compensation expense recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock Compensation Expense</i> – In February 2022, we entered into a new employment agreement with our Chief Executive Officer (“CEO”), effective April 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $165,000. Pursuant to the agreement, we issued our CEO a restricted stock unit (“RSU”) award for up to 150,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 50,000 shares; and (ii) Milestone 2 - Produce 2,000 ESSs in 2022 and continue his employment with our company until January 1, 2023: 100,000 shares. As of January 1, 2023, Milestone 1 was achieved, however, Milestone 2 was not achieved. The underlying 50,000 shares of common stock earned under Milestone 1 were issued to the CEO as of that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In February 2022, we entered into a new employment agreement with our Chief Financial Officer (“CFO”), effective March 1, 2022. The initial term of the employment agreement is one year and is automatically renewable for additional one-year terms unless either party chooses not to renew the agreement. The agreement provides for an initial annual salary of $125,000. Pursuant to the agreement, we issued our CFO an RSU award for up to 300,000 shares of our common stock upon achieving the following milestones (which achievements shall be determined by the Board): (i) Milestone 1 - Successfully complete an uplisting of our common stock in 2022 and continue his employment with our company until January 1, 2023: 250,000 shares; and (ii) Milestone 2 - successfully complete and file the Company’s Form 10-K for the year ended June 30, 2023 no later than September 29, 2023 and continue his employment with our company until January 1, 2024: 50,000 shares. Milestone 1 was achieved as of January 1, 2023, and the underlying 250,000 shares of common stock earned under Milestone 1 were issued to the CFO as of that date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the Company’s assessment of the probability of the CEO and CFO ultimately achieving each milestone specified under the RSU awards indicated above, the Company has calculated the grant date value of such awards and is amortizing it as stock compensation expense over the underlying performance periods. The Company has recognized stock compensation expense applicable to such RSU awards in the six months ended December 31, 2022 in the amount of $1,159,882.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In conjunction with our public offering in August 2022, we appointed two new independent directors and adopted a new compensation plan for all independent directors based on an annual compensation amount of $65,000 to be paid quarterly with not less than 70% of such amount paid in shares of our common stock, calculated based on the share price at the end of such prior fiscal quarter, and up to 30% paid in cash, with such final amounts to be determined by each director. As of December 31, 2022, we booked an initial accrual of $<span id="xdx_909_eus-gaap--DeferredCompensationLiabilityCurrentAndNoncurrent_iI_c20221231__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_zqeJI2X7YIq4" title="Accrued compensation expenses">97,500</span> of compensation expense (of which $87,750 will be settled through the issuance of shares) for our three independent directors under this plan. At the same time, we also granted <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220801__20221231__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_zjtvf8X6uLZb">26,000</span> shares, with a grant date value of $<span id="xdx_909_eus-gaap--StockGrantedDuringPeriodValueSharebasedCompensationGross_c20220801__20221231__srt--CounterpartyNameAxis__custom--ThreeIndependentDirectorsMember_zP4Eit4o8Yyi">97,500</span>, to various advisors pursuant to annual contracts for their services. In the six months ended December 31, 2022, we recognized total non-cash stock compensation expense of $<span id="xdx_90A_eus-gaap--ShareBasedCompensation_c20220701__20221231_z6eCBUJNLCtf">1,311,111</span> as follows: (i) $<span id="xdx_904_eus-gaap--ShareBasedCompensation_c20220701__20221231__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfRSUsGrantedMember_zGCOFbOV8Cd9">1,159,882</span> for the amortized value of the RSUs granted to our two executive officers, as previously described; (ii) $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20220701__20221231__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfNewCompensationPlanMember_zj0yW7pEky5i">87,750</span> for the amortized value of the portion of the new compensation plan for our independent directors that is attributable to stock; (iii) $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20220701__20221231__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedToVariousAdvisorsMember_zIWiJQgL87ke">48,750</span> for the amortized value of the shares granted to various advisors under their annual service contracts; and (iv) $<span id="xdx_901_eus-gaap--ShareBasedCompensation_c20220701__20221231__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesMember_z5m5Vp0m3p23">14,729</span> for the fair value of incentive shares earned by a wholesale dealer as of December 31, 2022 (see Note 4). There was a total of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20220701__20221231__srt--CounterpartyNameAxis__custom--ThreeGranteesMember_zasVqzo0vqVc">75,000</span> shares of common stock that were issued to three grantees, a director and two advisory board members, in the six months ended December 31, 2022, which were previously expensed in the year ended June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the six months ended December 31, 2021, the Company recognized non-cash stock compensation expense in the total amount of $<span id="xdx_90B_eus-gaap--ShareBasedCompensation_c20210701__20211231_zlM709Bsvr8i">4,001,558</span> as follows: (i) $<span id="xdx_903_eus-gaap--ShareBasedCompensation_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesMember_zRedznm9o9a8">3,505,000</span> for the fair value of 500,000 incentive shares earned as of December 31, 2021 by a company controlled by the Company’s CEO under a previous compensation plan (which were not issued until early 2022); (ii) $<span id="xdx_905_eus-gaap--ShareBasedCompensation_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--FairValueOfBonusSharesEarnedMember_zZwNzwwjN6ph">175,250</span> for the fair value of 25,000 bonus shares earned as of December 31, 2021 by an outside attorney (which were not issued until early 2022); (iii) $<span id="xdx_900_eus-gaap--ShareBasedCompensation_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesGrantedToAttorneyMember_zbziDNWwSWK9">157,746</span> for the amortized value of 50,000 shares granted to an attorney and a consultant pursuant to one year service agreements in mid 2021; (iv) $<span id="xdx_907_eus-gaap--ShareBasedCompensation_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--AmortizedValueOfSharesToNewIndependentDirectorMember_zdBQWjPXh5q6">103,500</span> for the amortized value of 50,000 shares attributable to a new independent director in early 2021; and (v) $<span id="xdx_908_eus-gaap--ShareBasedCompensation_c20210701__20211231__us-gaap--TransactionTypeAxis__custom--FairValueOfIncentiveSharesWholesaleDealerMember_zu3XAwldJMwf">60,062</span> for the fair value of 8,568 incentive shares earned by a wholesale dealer as of December 31, 2021 (see Note 4). There was a total of 154,165 shares of common stock that were issued to various grantees, primarily advisors, attorneys and consultants, in the six months ended December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Matters</i> – In February 2019, the Company’s Board of Directors approved the establishment of a new 2019 Stock Plan (“Plan”) with an authorization for the issuance of up to <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20190228__us-gaap--PlanNameAxis__custom--StockOptionPlan2019Member_zoogtKXtKbs2" title="Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized">2,500,000</span> shares of common stock. The Plan is designed to provide for future discretionary grants of stock options, stock awards and stock unit awards to key employees, consultants, advisors, and non-employee directors. As of December 31, 2022, the Company has made awards totaling <span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c20190201__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--CounterpartyNameAxis__custom--TwoExecutivesMember_zGAbZdfUUuB7">450,000</span> shares for the RSUs granted to two executives, as noted above, under the Plan.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> 4.00 1121250 4.00 4485000 3780000 58500 4.40 59251 9404867 1068000 267000 1283 203630 1179750 <table cellpadding="0" cellspacing="0" id="xdx_885_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zz89MxzNSZX4" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Equity (Details - Warrant activity)"> <tr style="vertical-align: bottom"> <td><span id="xdx_8BE_z9xC1k6gd64g"><b style="display: none">Schedule of warrants activity</b></span></td><td> </td> <td colspan="2" style="text-align: center">Number</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Wtd. Avg.</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Wtd. Avg.</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Aggregate</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Exercise</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Remaining</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Intrinsic</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Term (Yrs.)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Value</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td>Outstanding at July 1, 2022</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ClassOfWarrantOrRightOutstanding_iS_d0_c20220701__20221231_zx3WoCYJ4Mh6" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iS_d0_c20220701__20221231_zOm8EV8w3M7h" style="text-align: right">–</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%; text-align: left">Warrants issued to Public Investors</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98A_ecustom--WarrantsIssuedShares_c20220701__20221231__srt--CounterpartyNameAxis__custom--PublicInvestorsMember_zTpZ3trslnm5" style="width: 10%; text-align: right">1,121,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220701__20221231__srt--CounterpartyNameAxis__custom--PublicInvestorsMember_zWwO9oyQWnD2" style="width: 10%; text-align: right">4.00</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 10%; text-align: right"> </td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 1pt">Warrants issued to Underwriters</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_ecustom--WarrantsIssuedShares_c20220701__20221231__srt--CounterpartyNameAxis__custom--UnderwritersMember_zHo17r8683pe" style="border-bottom: Black 1pt solid; text-align: right">58,500</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20220701__20221231__srt--CounterpartyNameAxis__custom--UnderwritersMember_zq4gH3h165pa" style="border-bottom: Black 1pt solid; text-align: right">4.40</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Outstanding at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98E_eus-gaap--ClassOfWarrantOrRightOutstanding_iE_d0_c20220701__20221231_z6xsCmvU3rT9" style="border-bottom: Black 2.5pt double; text-align: right">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_987_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iE_d0_c20220701__20221231_z2jRRmW5uwX7" style="border-bottom: Black 2.5pt double; text-align: right">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_981_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231_zLy4gzjIwEMd" style="border-bottom: Black 2.5pt double; text-align: right">4.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_d0_c20221231_zBpQZL7Hxl3" style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Exercisable at December 31, 2022</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_ecustom--WarrantsExercisableShares_iI_c20221231_ziqKMAyDhDPd" style="border-bottom: Black 2.5pt double; text-align: right">1,179,750</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98B_ecustom--WarrantsExercisableWeightedAverageExercisePrice_iI_c20221231_zYHjQukHXPz1" style="border-bottom: Black 2.5pt double; text-align: right">4.02</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_986_ecustom--WarrantsAndRightsOutstandingTermExercisable_iI_dtY_c20221231_zA24AKF6Kjx8" style="border-bottom: Black 2.5pt double; text-align: right">4.5</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable_iI_d0_c20221231_zqJ2sYsdgN3f" style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 0 1121250 4.00 58500 4.40 1179750 4.02 P4Y6M 0 1179750 4.02 P4Y6M 0 97500 26000 97500 1311111 1159882 87750 48750 14729 75000 4001558 3505000 175250 157746 103500 60062 2500000 450000 <p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_z2CSMG7xw4fi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(4)       <span id="xdx_820_zBoY1wANoxFa">Commitments and Contingencies</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Effective January 1, 2021, the Company secured new corporate and manufacturing office space under a sublease agreement with its contract manufacturer. Under the terms of the sublease agreement, the Company is required to make rental payments of $10,350 per month during the initial one-year term of the agreement. The sublease agreement is renewable upon mutual agreement of both parties for up to four additional years at a modest increase in the monthly rent, however, the Company is under is no obligation to renew it. Management has determined that the exercise of the renewal option is not reasonably certain and, as such, the Company has accounted for it as a short-term lease under ASC 842, <i>Leases</i>. Effective January 1, 2023, the Company elected to renew the agreement for another one year period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As indicated in Note 1, the Company sells its proprietary ESS units through wholesale dealers, primarily in California. In that regard, the Company has entered into agreements with several wholesale dealers operating in California and other states under which the Company has incentivized the dealers to achieve quarterly sales above targeted levels by agreeing to grant them shares of the Company’s common stock for exceeding such quarterly sales targets, subject to defined maximums.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time in the ordinary course of our business, the Company may be involved in legal proceedings, the outcomes of which may not be determinable. The Company is not involved in any legal proceedings at this time. The results of litigation are inherently unpredictable. Any claims against us, whether meritorious or not, could be time consuming, result in costly litigation, require significant amounts of management time and result in diversion of significant resources. We are not able to estimate an aggregate amount or range of reasonably possible losses for those legal matters for which losses are not probable and estimable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p id="xdx_803_eus-gaap--SubsequentEventsTextBlock_zPPLPIqKxUn7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>(5)        <span id="xdx_82B_zuU5gxQGw3i1">Subsequent Events</span> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of January 1, 2023, we issued a total of 300,000 shares of common stock to our two executive officers in recognition of each officer having achieved Milestone 1 under their respective Board approved RSU awards (see Note 3).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"> </p> EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ^(2E8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " /B$I6P%T4ZNT K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)TU!)'1S6?&D(+B@> O)[&ZP24,RTN[;V\;=+J(/X#$S?[[Y M!J8S49HAX7,:(B9RF&\FWXMU*+-4_L:4#[)R&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ M#XA*5GE']J5G!@ N"0 !@ !X;"]W;W)KST5K'C"U*E8 M\Q2N+(1,F(9#N>RIM>0LS(.2N$<=9]A+6)1VQA?YN3LYOA"9CJ.4WTFBLB1A M\NF*QV)[V7$[NQ/WT7*ES8G>^&+-EGS&]>?UG82CWEXEC!*>JDBD1/+%96?B MOO6]D0G([_@2\:UZ]ID8*W,AOIF#V_"RXY@6\9@'VD@P^+?A/H]CHP3M^*<4 M[>R_TP0^_[Q3O\G-@YDY4]P7\=#FOF0]TT>#6ZBU SC3$NX&D&<'OMBPR7I$K5BDJN+G@9-77-$D$'6:O+PM.:V[L'#7:?[R68"C3)3]ZU: MLX!?=F!N*BXWO#/^Y2=WZ/R&6.KO+?71-DW 3YA[NHG9TN8)CU^P6-FZPD?# M&IH:[$T-CANG3QF3FLOXB=SSM9#:Y@^7TC*SVD.C&MH;[NT-CTQ#R:"$YA6P MWA^N53M^:%A#@V=[@V?'&;SC,A*A*2<$"IIURAU0VA60V@J"QC?T.=K['!WG M\R92 8MW=F_@M+7ZXFJ?K/[0F(;^SO?^SG_(WU^)2#HSH67_D>O81;0-L MW(IL7!Q-2I\/[)'T.Z#GYW1H+45X<%._%?2X.*J4 M?B'KA 08R*V>D)F&4D2$)+[(8,!AW$5H3VMBDM3\(0 MU-7)[@-Y#_>1CZG=)R[I>L.!"_4[C7BL(%?@&BRGK-[;0"2W8B071QO4^\-6 M6+WCDK,L@ER96,VVP4EN!4HNSC8OS?KF")+Z06Q3JU%<[DYLF:W>^7A<4YL5 M+[DXY+RTN9^\=U)LHC2P)S2NZ=O'LPUNHA4W41QT7AJ]$TK#;]'?T;JV/AU0 M/*?.L&_=(F@#G&@%3A1GGCQ3)Y*S>F.XP)N1X_QJ-=8&,-$*F"C..>]%OF19 MB10CP@,BWK#?'?1K!JX-3*(5)M'C,*DD_&*!':7+?%+:5S '%*>VFNSC04UM M5I1$CZ*DVU1S66RCFL4+V_FVVL05:VRV 4>T@B-Z%!R9]0N@$%35I9!6XCV@ M,Q5IEP4!!QD0"0M!J]\VR(A69$2/(J-9PN*87&4*+BM[SN(Z=?M?>%A3>Q7\ MT*/@YSKAVC%/?0 ]Y@G')!F4Z&!=<7+]J+G98G^^ UAL'EFMX]]1NP6(QS7U7L$0/0J&9BL.*8R-+"Y3;Z\- M!/(J!/*.0B PEN3+#!%\ ^#+G[R0CYD&'DI#2&WK8X970IKR\4.AUL_5S).^ MS=CSW/[ &XXN>AN;QPI^O /P\YVY-9-DP^*,DY^=4\=QR1IJR@-G#+JW#+PS'I1^8WKM1"5_OX5S;MG K6/)RMCICW MN("9]U^MQMJ@,Z^B,P\GIQ^8^+@0,O%?E<%ZS]X-,>BOB>S/ M[E_+F>0OH_2JVXMW>CXP0]Z*Q'P!H<[I&4Q 6;PF4QQHL<[?-)D+K462?UQQ M%G)I;H#K"R'T[L!\P?YEI?&_4$L#!!0 ( ^(2E9#AQ*>\00 (\3 8 M >&PO=V]R:W-H965T&ULK5C;;N,V$/T50EVT6<")>-$U MM0UL'!3= FV#3=,^,S(3$Y%$+TG9FWY]2=F1+Z1D+YJ'Q+K,')T9DG.&'*^% M?%$+QC3X5I6UF@0+K9?78:B*!:NHNA)+5ILW3T)65)M;^1RJI61TWCI598@A M3,**\CJ8CMMG=W(Z%HTN>L-*L9X$*'A[\(4_+[1]$$['2_K, M[IE^6-Y)L5IQ40/)GB;!)W0]P\0ZM!9_<[96>]? AO(HQ(N]^3R? M!- R8B4KM(6@YF?%9JPL+9+A\74+&G3?M([[UV_HO[3!FV >J6(S4?[#YWHQ M";( S-D3;4K]1:Q_9=N 8HM7B%*U_\%Z:PL#4#1*BVKK;!A4O-[\TF_;1.PY MH*C' 6\=\+D.9.O09B[<,&O#NJ6:3L=2K(&TU@;-7K2Y:;U--+RVPWBOI7G+ MC9^>WM"2U@4#]Q9!@8N'FC9SKMG\([@$#_>WX.+#QW&HS9>L?5AL46\VJ+@' M]9855X"@$< 08X_[;-C]MZ8V[M#G'IKXNB!Q%R1N\>(>O%DC):LUH$J9(*]] M\6P B!_ KJ5KM:0%FP1FL2@F5RR8_O@#2N#/ONC>">P@5M+%2H;0IS.J%H#6 M.X+2E&1^JG%'-1ZD M^KE>F1P*^>KC%KO?-!_,27+$S;7#F&08]G!+.F[)(+<[R9:4SP&O52/;Q6R' M7^@%DZ:"[,]\'_G$)94F48J/N'O,2 XA\E-/.^KI(/6_A*;E&213Y^LICG*< M9D9=32S,VCVT\O.I.?:#=++.WKY6>6MY/21EUQSYJ]Q^7O6 MN'<".P@8P9UJP?-*QY*^VKKAE2CHSMD\0?!H4'QF,$X@] \*VE-6=(JC;)A= MEYJ9'.A!KL@AX?!T36(2[1690YH[;42#6)/K4OC8[WP MF>&4Q'UD=^*&3JB;,(58:F[2"&JAV? $(*>3ZIH@F&2P=_1WVH:&Q>VPM)U* MJRM;44H2)ZT>=8OBB.0]!03MY T-Z]OWY=45,B>OKDE,4M0W_CNI0\-:M\GJ MJ6RZ8N7-IFN&8IBA/CU&.U5#P[(V$U7%=66[KDTK)FK-ZV=6%X8QN/C#)!A$ M_K9Z$-A?5H&WP?[_0(?![[0298-J=*]%\;(0Y9Q)]5/;@.I7KQRA0=']7CUZ M+[3#J'<2C 8%KQURLRM5-O@1^ "O3&]DUI $IOMN3%N+(!S!S1]0"VHH -KH MA9#\7S8? 8)'612/2)*U$P:C49ZF(QRC-V.NE"W/;6?7:*7-A9E1WK3FSK0F M.(N.FU&/&49YVC/W\4Z9\0EEGIOMH]F@FV5JN])+7IN=R)*;9>O==GG$-TKB M*$[C([X>2Y21/$JBGAX4[X0:GQ3JIFI*:G:]]@2 %]R[!<&N %^B-,KBV.DI MO*9QFN;TJ@\JPR+VE7B5,,48[0,677$"T]_<^TQ]'?7X=YIB3VJ^IW*9[-W B5[,I[P*C6536Y.?S8W M6BS; Y1'H;6HVLL%HX:X-3#OGX0IZ-L;>R;3G<%-_P-02P,$% @ #XA* M5B-C2V2? @ 0@< !@ !X;"]W;W)K:K21EK(T$1&I.F552PAVD/;G+;6#AV9]^T;+]^MA.B BF# M:7E(_''/\3G7SO5X*]6M+@&0W%5TQ7, :_7,V5Z?L=2L J$9E(0!3%,;[P)N&&SU3IM8)PLI M;VWGLIAX@14$''*T#-1\-C %SBV1D?&SY?2Z)2UPMWW/?N&\&R\+JF$J^3=6 M8#GQCCU2P)+6'*_D]A.T?A++ETNNW9MLF]@D]4A>:Y15"S8**B::+[UK\[ # M"(=[ %$+B%X*B%M [(PVRIRM44Y$#F5L&30ZN!:T+AE Q8ZAWQ XO"(1$$4]<"GS\,_U\+ @SZX;RQWOJ/.=^3XDCU\BSVG#'_=SVQSO1:YK#Q#-_E@:U M 2][]R9,@X]]QO\3V8,TQ%T:XN?8LZFL*N-VCC*_/2)FPXE4Q.6F(#>4UT!F M8 ;LGO?EH2$?.7);+S99, B"<.QO=@W^+>J!\F&G?/@*Y4ZA)J0#U4FG.GFUZB-RJ77=+SEY(B2.CH=)G!X_4OPT, H_ MC$91LB?-:2DX_3O MEY04V9:.M4'7>8AUF3/D\)##(XYV0GY6:\XU>BWR4HV=M=:;&]=5BS4O$G4M M-KPT;Y9"%HDVMW+EJHWD25H%%;GK81RX19*5SF14/;N7DY'8ZCPK^;U$:EL4 MB?SOCN=B-W:(\_;@(5NMM7W@3D:;9,4?N7[:W$MSY[8L:5;P4F6B1)(OQ\XM MN9F3P 94B#\SOE,'U\A*>1;BL[WYD(X=;'O$<[[0EB(Q/R]\RO/<,IE^_-N0 M.FV;-O#P^HW]YTJ\$?.<*#X5^5]9JM=C)W)0RI?)-MUN@30!] M;PNL":BDN[7V:N!FB4XF(REV2%JT8;,7U>A7T6:\LM).E$^= MX/?1)U'JM4+S,N4I$#\;C@\&XEVCM17LO0F^\P8)9WQQC7SR(_*PYP']F;X_ MG$!ROJWU^?]N_6@P_#;[?L7'3O!]*!>BX*B=!.COVV>EI5F]_T"IKLE\F,Q: MVHW:) L^=HQG*2Y?N#/YX3L2X)^@<3XGV>R<9/,SD1UEA+89H4/LDP?^PLLM M5V@I18$69N[;;"CC"GK=^ &7"DI.S1M4O'9[>)FP("28C=R7PV'OPPCV&?'" M8]RLC_,(IC$EQ[@Y@ M\&OI[W-$XL'81]:0CJ7T8)1X^E=RP51H.VDZSS90K MQ%]-Q:.XNH$$A^>TFW.2SG8=R*C[_B MM8HG'.QL;L@)#WN=2$,>VNO#PH\C^&.ZC[*BX(NUQS@"A@^H9C@ M?;F'!S7_(;1)M^@M0+"RPT"^(T+#[IX" *G)9$B["0> MI*)#G35ZB%&%F#& M@A,#<%#ODL$!^&A-MMI<15OL@N))KP=7<12RWF2'@!2;3="C7?4 D@01B:/N MI@IR$AHQCYW0[^WU>\/>J]=_K48P&7YO2N#N3.Q#KGSF=_T'@AE_IMTY",!BYI]:@/L" MEPQ7N(T#@=,0%$Z_+KP/ 84#,$@X !L0OJ]HR7!)^QO7*#?N XKLUY0GW 8 M&K>)(]9S&P!IW"8@A'4%0YR$13@X4>>1?4E+OJVF;<(//Q^@HA: @54M@ /+ M6@ 'UK7NP<&*^>Y:52=:RGR6;4M=?V6W3]M3L]OJK*CS_([<3 GP?&9/V:J# MG#U]?43W*9&KK%0HYTO3%+X.39)D?>I5WVBQJ8YUGH4V'X75Y9HG*9<68-XO MA=!O-[:!]NQQ\@502P,$% @ #XA*5MK:^!XA P _ H !@ !X;"]W M;W)KN MJ*CKP[0'DUP@:A(SVX'NW\]V0@JI06SC!6+GGG-]SK6=V]L2^L)6 !R]IDG& M^L:*\W77-%FX@A2S!EE#)MXL"$TQ%T.Z--F: HX4*$U,Q[)\,\5Q9@0]-3>E M08_D/(DSF%+$\C3%]/<0$K+M&[:QFWB,ERLN)\R@M\9+F %_6D^I&)D52Q2G MD+&89(C"HF\,[.ZD)>-5P/<8MFSO&4DEY. NZAN67! D$'+)@,7?!D:0 M)))(+.-7R6E4*25P_WG'_D5I%UKFF,&(),]QQ%=]HVV@"!8X3_@CV7Z%4H\G M^4*2,/6+MD6L[QLHS!DG:0D6*TCCK/C'KZ4/>P#!HP"5 23<+[8XZ%&R151&"S;YH-Q7:.%7G,E],N-4O(T%C@"C*%)%D&DP8]/X_T3>%/(KSQP=AX,G9.$8P@; MR+5OD&,YCF8]H_/AMD[._V6?_'/V S/<:D.XBL\[PG>7A20%5.T+]&,P9YR* M _U35^J"S-63R4NNR]8XA+XA;C$&= -&\.F#[5N?=3Y?DFQ\2;+)A<@.*M*L M*M(\Q1X\J\L.(C38B-.Y!/0M3^= Y7F=J2.('G+..,ZB.%O>H"%F<:@K59&E MJ;+(S\LV^V5X'VAW.IVVWW8/ \<:1JMC^XY=8YQH&=N.Z[T% M'ECC5=9XE[1F'"JJZ:'/O[(ULR/16M7 M=&)O]$5?>(_I,A9?_P06(I75:(G-28M>JQAPLE;-Q)QPT9JHQY5H3X'* /%^ M00C?#62"JN$-_@!02P,$% @ #XA*5F\!SBAZ" W3P !@ !X;"]W M;W)KT!-ML*%)'0G;NVQ>D%%$$EBM2 U]>Q'I8_ 'N+H#]$=3- M:UE]K9^E5-ZW35[4M[-GI;;OY_-Z]2PW:?VNW,I"?_-85IM4Z;?5T[S>5C)= MMXTV^9SZ?CC?I%DQN[MI/_M4W=V4.Y5GA?Q4>?5NLTFKWS[*O'R]G9'9]P\^ M9T_/JOE@?G>S39_DO51?MI\J_6Y^5%EG&UG465EXE7R\G7T@[Q/.FP:MQ;\R M^5J?O/::2WDHRZ_-FY_7MS._&9',Y4HU$JG^\R(7,L\;)3V.7P^BLV.?3IS^?I7>;B@H-%;E7G=_N^] M[FV%F'FK7:W*S:&Q'L$F*_9_TV\'1YPTH'2@ 3TTH$8#%@XT8(<&S.QA:$C\ MT( ;#0@;:! <&K27/M]?>^NX9:K2NYNJ?/6JQEJK-2]:[[>MM;^RHDF4>U7I M;S/=3MW=JU1)'7A5>^6C=Z_*U=?G,E_+JOZSE_RZR]1OW@]?BG2WSI1<_^A= M>U_NE]X/?_SQ9JYT[XW&?'7HZ>.^)SK0TZ+<;'1FM%UX__E%;AYD]5] 9H'+ M?%CKH>@42W/O4YJMK[/"6Z3;3.GWB.@2%_TLE9Y3>2]IOI->JKR_[8IW'O.O M/.I3 H5B+QVVTLU:\7)'XI!KTY=33P-6C(0Q"UG?<&D;7A/?YSX3?M\RL2T9 MX5'(^-&NYPQV= 9#G7'_G%:ROO+^L5.U2HNU=LN5UWGHX]Y#HURS[X@;KO&C M*#*\@XZH6<#?U]MT)6]G>H6N9?4B9W=_^@,)_;] ^>=2+'$DUHL$/T:"HY'X MN:YWK:_UD MH+!P*W&HSXV(<#MTOHB-7$6'#SO'@YP,=$8C!J=Q<'1>\.;.N_+J=C) 3@RL M,5-?SV9CDB[004[-;)=BB2.Q7G#"8W!"?(UI(Z'#HHNP.FW+&/FM>2TA5X?V MVAF8^1K:*<1\'IH9BPYK0L:"W85T(&?%T2T"=3"I6?X,_(OKY($!(:B6>;\2#RC?1, #&N$VO 5_'15_&%LPU; MX&([Q0-.PL"8>&C74QRXG?%?L^ZO2DK9R @O)>;O&JZ2#CPA^#\@Y5#>-.)%[IPJK9TJI80FXYT4:"+ MAY ,)'R'2 1GI,$]:BE7.K\)DM_!N#W*IB0B_(@+DY.6@.4UT9=)0TK-!0! MKSB@9*A,(AV5D#-8,GH!..\@@! &]J@+F 3)/9=JB2NU?CPZ'"(X#V%[U/DJ M08Q+41M0ALHH"&4&RBC;%"^C.NPA./>X+*-LVAA*T0M@"4E1EVJ)*[5^/#JT M(I>R%>CR"Y@$I$YBTQF+A!\S*VD=]9B,Z+%_[[TC)8J3$K;-XTTG.,R5T)(" M,,5]&D?F+:EDC&7?91U,41RF+M^X#\+G5D4*(!:\<0.60QLW8(INW/3D_ :' M&8<;-P68!5X5\3%-716=JB6NU/KQZ$B*XB0U%BXI& %FGT^06)C@1 '$BEC, M+0Q= I;7)!!QS,P]/@%,:4@$I4-3MH,9BL/,97 ).\@F@L9!@@;6J:-3KG&J MEKA2Z\>C8Q]ZX?E05GB[8BVKURI32A;>=O>09RMM]B@K'2DP( -$6H%P^86 M)D1,(V[FZP5',^">#?88^=P?VK,[4J(X*5WJ/>R&,P6027N1!N:9&CZVR5GM ME)AG4 G88S.G!D"+=J!% M<=!ZZ_-C:M.7]BB)0F$ZU2E\.55+7*GU8]3!%W4)7[C8%):P42B(262=^;GJ M,#G?8?])GPZ]V.7HA3>=X"Y70DL& %6H<2HR')^,,.P[K ,O=B%XG=YM 8LV M9H,7HT*810(#&(EIR&:!2?: Y34)>2SBB)C^L$T%%S[A W4 Z\"+N0*O\PX" MSG6T@WQFWEU;X&.:_+B84_!RI=:/Q\FS>V\(7FP<>+'1X 58#H$78(J"%^O MB_UNX,5&@Q<^ILDIZA2\7*GUX]&!%\/!"]US7#[AMG"JMG2JEC#HO"N,0D*& MUN2.S1C.9J-N#L+Y;3]IQS2>AF9RVZ!&>1CP0%A[E&UY302/@H"8Q_J J: ^ MBZH' M1R :5T;9=#541@'/W V54;8I7D9U(,/.@(S#,@HXIQDHHYP^NN=4+7&EUG_N MON,BCG/1-+#D]@-[YDJXX#:2"!)3:AZGX .;\DP]W&$\D*N\0R".(Q"V?^-- M)S"C*Z$E!R@ICD1 S4=O1QCV'=8Q$C_#2!<]?LMM'!*![YOW0O&^ITYBIVJ) M*[6^WSL6XC@+75X'<1N$H#H(,!NH@P#+H3H(,$7K('[R:R)7('3>038(#=1! M^)@FYZ=3$'*EMH_'_.27H&PO=V]R:W-H965T&ULK5E;;]LV M%/XKA#<,+=#4(G5UEAA(W!7K0[>@0;9G6J)CKK*HDK2=_/L=4HIE2Q23 O9# M+,F'1]^Y?H?,U5[([VK-F$9/F[)2UY.UUO7E=*KR-=M0]5'4K()?5D)NJ(9; M^3A5M62TL(LVY90$03+=4%Y-YE?VV9V<7XFM+GG%[B12V\V&RN=;5HK]]01/ M7AY\XX]K;1Y,YU! 81*UFNC0H*7SNV8&5I- &.'ZW2R>&=9N'Q]8OV MS]9X,&9)%5N(\E]>Z/7U))N@@JWHMM3?Q/Y/UAH4&WVY*)7]B_:-;)I,4+Y5 M6FS:Q8!@PZOFFSZUCCA: 'K<"TB[@/071",+PG9!: UMD%FS/E%-YU=2[)$T MTJ#-7%C?V-5@#:],&.^UA%\YK-/S>TTU@[!HA<0*+:A:H\\06H7>/51T6W#- MBO?H CW4?48@_(!(0XL"S>/MR[($3'OP76GWQB#[KL97UV$J*#8+ZDE3S MZK%)4*XY4Y40BF7DYB>-6L0+QZB6(HG*'+CYGZ,ZD M[,0[R<$[B3=T]UKDWU$N-D *RAJ,V).Y9BZS&UW148QPB,VG%\NA7!0$.(XS M=RC3 ]C4"_:6%M"?E]H',1V\.@O@TP,XE KF3*I$Z^E1*R M#5&E&.0T$+LS9.;/I3,I.O# [>&'F#=!-GHNM*32H,L9W=%DZ M8S0;>/\B3L,H[+<$AUQ(XB"(W+'"0<=X@1?GEVH'$1+RV3E.X]FL7Z@NP2B$=!U!V9$V]C*B02FWT.O; M5N)V9>A &<11TD]4AR">C3FR8U7LI]6_3<0_&&YR@HL\/:R%-12YB*,H'@'6 M,2KV4I+E^[R;>GJ<>3+X.)''0UA)E@6SL(_?(1A!EI!PQ(*.]7#R4S/;BE=0 M:&^8V;"73G^V5Y]+VZD7.CK%?CY]@(%<[B77FE6HWBY+GL,68,6D<03L!6 L MV,! H,R,X'3&D$;#- NB8% ?;^9;W!$N]C(9=$F1,U:T 82A;L>DYDLSV G- M_-TG>[UTAB(X2++C2>(4=T>1V,^1O>*II=AQV!>AY;,S"YWXA\0XXO>AH-<* MTC$H\3.HL8)7N62P?[9#C['(T)2]8#^VP/ZEF;E=^,F0.<, JAKW*=8A"-4? MI".ME7042_P4NQB#BZA&2_;(JZJM >AI7!1.*X8$&H9!F/6#X)"+2)QD(_L: MTA$M\1.MUPAF1@8O_"&SAA$AR1%OM?B'@CC :3HVS9..@XE_YWR_K>O2'CW0 M$A5JB2:8W=E=R5HH_E[935W043_P4O["\:$]<+:%W+&DWTJ9[T'82?LDV MY7XRI'2,TQG)DGZ '8(D&YG@2$?_Q$__W;&.,>T>$=JW)[[,'8ID*<9)S[+ITV"MD(71 MG'D>GAX.Q6_L47#O^2V^7#1'VYV:YJ3]*Y7 6 J5; 4J@X\I%(9L#J^;&RUJ M>_Z[%%J+C;U<,PK#GQ& WU<"1J;VQKS@\"^$^?]02P,$% @ #XA*5MP9 MQ_CO!P BQ( !@ !X;"]W;W)KO(#R+00LHMB3'=M)<@%Q:;!;M;I"T,P^+?: EVN9$(E62LN/]]?L=4I;E M-LU,@7U):(KG_IWO4#K?:/-D5T(X]ER5REX,5L[5[T8CFZ]$Q>U0UT+AR4*; MBCO\-,N1K8W@A1>JRE&6)--1Q:4:7)[[O7MS>:X;5THE[@VS355QL[T6I=Y< M#-+!;N-!+E>.-D:7YS5?BD?AOM3W!K]&G99"5D)9J14S8G$QN$K?71_3>7_@ M-RDVMK=F%,EJ?] M@X\=LZ_%T6;G4Q.!FP0BQX4[H'O?F[:..9D+Y6.= MKEIA>%!)%?[SYS8/?T4@:P4R[W&LY)145Y M= 9/)>3YU*7,I[/G( MP3BI&.6MH>M@*/N!H2G[I)5;6?9>%:(XE!_!Z<[S;.?Y=?:JPEN1#]DXC5F6 M9-DK^L9=)L9>W^0'^OYEEES)_W("2\QNM+*(M> !.TC.O1%6*!2XN!C79,FLQN/SUEW2: MG+T2WG$7WO%KVO^?A7[5T,MAO&'I6[9S(?HY%]BML+F1-24^PO$NDCOEA)%5 MKQ)W*M 4E>B&VY4/UB_>?VWDFI>^2.,XG67Q]'2&\VOL:+.-'L%V15,*\D?N M=F$Y%]5<&(^S?S1*L'$21P]\@Q8DV[RT[&\LC:>S:9P>IWY]GT>]@ M(ZABM=$Y>3O-XMGIA&7X-SV)X+-$UQ9LJ75AV:^_G&1I>L;&LS0>GZ;19^T0 M#JF;C4_BT_$4ZRS.L,Z2$_9Y)0#0JN9JRVJXH0LDKRRW8,DUT5;D< #1-B$< M@-.2)_NX*"U&Y-H4A <&6;U!"@5S&OM%0RNHR+DQ6RK%7E>G B?I" 21'CS) MM75,&Z8P2# =2G32O!11D"3>+!B*(I%^;BWR0?U"<@#!$T1RK0I)=;-QWTAC ME%[# #F<-\:0$#@Q?V*E6(O2#O#]BILES#H=!><6;;+1 MV,60_5.S!^A0<.\!J0 $/<#0<"?C,W970*L'Y:[??4) 8=3=(&D'<+4$+&3(#Z$G(2N**4L)?)?D0/AHA(MODJT[6B#J0/]#$:S3TLZ3^AVPV8^DI M2S,V35F*]82E8_IYU744U+);W!QH7X%QU!V]VH9(6T>:E)P./V(##'GUJ,B><:US??Q&PNN@>!2$C( M".*(8=1/GB#2\<@ZY+GM/I/?&.SXB?+'*TH8EMR!G12NIL%AX6G4LDK#YU(^ M4?UQ2#&E7? /J+&D';J:&MK$,^_ZF%S!3=$#AUGA7!G4=F4CCWCC5AHT1DW4 M=B5M_]$8:<'Q7=E#720XK0X]-$1QB14I!;@Q!Y/OGVDMV$>-\7./QL#3"ON/ M*Z+'-)YDI_%LDF"59FF<834YB2> Y7@2X/D T'.3AS%Z2X2K:W(ZN@&?6O;% M^MJ]MR$JB_-H2 1_SXT/X0.7)OK-3X!/>W"$LO2'-JY,37B",GI4B9;?=YRV M@*9V"JTD0H936T_R10O- NE'R[UC'TDN2MD1^Z)X\0<*@F=?&TW_/!NV?4/$ MT0X?&VI-ZM!/F$T2DPL0]I;[J"YX"VCI>1XS-P:DT , NT$8]7,MJW MN8V9D-Y"(8%^!YR2SVKW*XZ"&>*$0_.DTLI*EMR\',OWN3M[0467'O9G^N#) M]T6@?@I&SF#O]83]7&+8&S%<#NF&@1&+LC'?/&_/HC =O*E.8X&;U3I8 E!K M?\'R$PH:02E&S[7Q<)]O^];;"PVPPND)G?1SBJ:H:0,!J%2'B_$>%YWM.WUP0+=$+FKOQ- /D^^O;SOVT^IHSDL:&T?^U3':,[3L=6-OUA5D M'K;W#EA6--W5 E/ N".ZMS#PW8[45^"/OD+O%K9>MM9B/\IW%W>_$/N+>[P? MBP"RD#[4WF;-M^T.A$NMEL&A0LS=CQ)R>*H?,&XC^USCA:.]$IN6XJCRX4+< M(JDOVEU56RRT%'WE#E\HZ,75^TIO%A'>+/S.X:6JD 7Z@>YBXINW(Z.5IGD6 MDO=1(D\%0?RE=\51[P,![E)+_QD$;I*R\*V@V^V^M%R%#PS[X^$SS2=! 3 D !@ !X;"]W;W)KF3FSPW4GU9VN$ T\-+70FZ RICV+ M(IU7V# ]E2T*>K.3JF&&'E49Z58A*[Q34T=I'"^BAG$1;-=^[T9MU]*:F@N\ M4:!MTS"UO\!:=IL@"0X;WWE9&;<1;=(-"?='^197C'#MFLE.U#.FM#< MPH?JO8D<%ZXHMT;16TY^9OM5&M1PP_8LJW$=&8)T+Z)\<+_HW=,7W!=P+86I M-'P2!19/_2.B,O))#WPNTEG\ M-?1_K\2K[L^3>Y]^ (\[&7#ABX!(705SROHD&HH M%2^YH(/VP+6V6("1<,\4EU93F^<*"VYHEQ,8-1 1(<;7;$]TDQ70H? M-S)# MY?B3U%BIL <9SG>LN:+FSLR$"]IG]-*PVE$\#1?+)%PMEBZ5!U"BAX#"$#MW MK)&3HTC 17((I#^,;C6C^^0S*)6TK8-^ECK=N^1#3B5S*$KFQ-4GZVT2S\/% M:C6%3XQ28X7&W#H"_KS')$TR24GCGAW5C-$?* =&&$GZ"[24"":$;<8D,PTU M&2BZ=0N;$V*VA\8:2QD8Z;MTS::GIT?^1VD^G<*MS33^L&1:[T.7TJ,,U8SD7L"VOHR#[$.A?;B=BZ]0EDC+17'T863TS ] M24BQ7^_\A7DC">+$*XSB&!:2+I5_-B2 \=Y=&1Q.N M057Z.:Z)* 7;#[MQ=_Q4..\GY*-Y_YUQS10U!BD<=^0:3Y&PO=V]R:W-H965TUQ>#@Z=*L[GN MI;W=@P]ZN?+T8'!S5E3^8_W>XF[0:2GT6E5.FTI8M;CNW:87=R/:SQO^ MT&KC#M:"/)D;\YENWA37O80 J5+EGC1(7)[4O2I+4@087UJ=O:\<=ZL M6V$@6.LJ7.77-@X' K/D!P)9*Y Q[F"(4?XFO;RYLF8C+.V&-EJPJRP-<+JB MI#QZBW\UY/S-JR^-]MNK@8C+(6[F[()?]0&XBWIG*KYQX516J.)8? $,' M)-L!N5?B;ROMBF,8B2[+L&7W#SK$AZQL_ZYCXQ^W<>8O<__.4CT'%\+0* MZH<+5\M<7?=0\$[9)]6[^?6G=))J$G4S+W4>F<5"65TM8R&%-UZ6PBQ$ M&J=9&F?C)(B/XM%L'"=8#>/I+.'5>!:/Z:_^B-7GIOI74X4^VVB_8GO?FRA+ ML3(E4#@R0WL MI;5]M>?9EDZO71(?CHC;4_*>CTOE:B,5T[HX$% *->FJ3QI M^%F,SX$S%>?Q*!G%L\D4V)/)C"%FDRE?6^^=_BK6H605E:Q P:GU7-FH+3K\ MTKYO /X 4"VWDNY6\@FNM&MW_R15_< M/BW[!ZO;G;ODYZNORN;:*?%!T$28AZ<7;IMR*%IY@W]++W37JXJ>=HV0@$N^Y+&'N"4DQ MUGU3[J=$/NXZAPKCH/2_A?)=N [2!MT9?L9(\0Y<&P3.X'\M376 ^'4IV*#( M6LB1/M&1LCI% $(%TM@W*>H YZ*QJEW"@D/1"[6N2[-5R+O%;?6RN\]153BD M)9M27VFM4'FY65;Z3X7L!R:Z/]SVJMV&WGRMYK;!., >QW #I4<-0UX@]%)4 M.-F#,(5NV4:*^Y76BW$:UVAO32Z[V&Q0.58<4:ARI++^]!,0[:?/5KG+ZW%>H1$\:/!5=8(#HI&T-@JB4V"IIN=EQ+QN^2&KJL'%@7GLEADSS9C*^V@#ZQI4SHX<.F6< M@[;V.;JO'TCEA\>/0J+:BHAL-#7)#9-P&KC0L-!/ GDX@!RGO:EY]$*& E$> MD==:E]2#%63/-BN-;(2=C,.16IP8 M ;T6B$9?W&&"+T)5G@AP)!T:SW$,V@$ K367YPG)?W((.8;W0'6[2T;43C0,%2,-3F.;F*?!NU +#@.$$&"5O2MY!HDLB M?'9'/-&!2+!02ZN=OAT?K0U&EC\)C_84B!#!DW0-L_;;3-3*\CL?1I8(:VT* M%VCG$-J>YY]3+VOT7LYLB-PPUB/__\/A(]H-3OL!$"=^1NC?DN M,#!HZZ2&:,[E1Y18[HN>(TQ4?UE:'C;-!,C31YCR;T",XTUG '_!SH1WD=[A"/^]. MAE\Z\[ETJSA 9MF%KKHIWD7!OV.&Y_[9!0V3(V/_KAPX=?2^3]DX./-H[@XO M,C^+\RD/:]F$8]G>I?$P1>&DJ>C*1\RF8DTP\\#3Q M3GJ>6#/ZB\5&+;N>>GT=''Q$6"N[Y$\E(!\"$KXG=$^[KS&WX2/$?GOXE(/) M:HE1'M6Y@&C2G^(EW8;/(^'&FYH_2&PO=V]R:W-H965T MO0\TO3T7RT7?ALJCK*PO3LI%,57W'\TGWR>)ON4$K3 ML@W&6?*\.AV=SU]?',K^M.$WP^NP]TP2R=*Y:WGY4)Z.9D*(&]91$!1^;OB2 MFT: 0./K@#G:N13#_> M(\'3K@GI+ZWSWJ/%B'0?HFL'8S!HC/8-@\5@L$B\LZ/$\JV* MZNS$NS5YV0TT>4BA)FN0,U:2%P M,HUP(1NG>H"[R'"+;\"]I(\ J .]LR67]^VGH+;CM]CRNU@\"?B6]80.YF-: MS!:+)_ .=O$>)+RC_Q,OO35!-R[TGNF/\V6('D7SYV,J9"<'CSN11GH=.J7Y M=(1.">QO>'3V_-G\Y>S-$R$<[D(X? K]OZ?L2;C'R7Y_^ /M^2D>2O5NM>+4 M4?23LCWZF7*2YN,BUBS&G;(;"JRA9DD6_:F=[YQ7D1/M%F8KZ-M[@));K8QF M2D2H1_%X4I@4RX;1O9PV$_H2S(%@R*R;P-PY>41 MI#'MTS0!$^9K;X1J=,"\9BS8J!KJU"9K#:COYK/QP=&,.OAHI="IS/0%RU@3 M#0R*M& M#A12=0DNX4<2?F"_!"O-/N)$D4(9$T!#K^O[Y,25TMKU-L*3*&&B[$35U,[' M%T*"LL8YB/.K2SH^7(SI9UD,=!X@16FT$GNX^L6A,.?)27%7O4T34KEUWG7> M<)1"?W=U!4Q9C;5W?573NG8-!X7$E8R_/HQA8'#*&<0"[$O5&%"T1DWH@\VZ M>*Z4+Q\&!1W9)TK1%;OB-MW:(RP=7IZY15OM7,I9E19;J?$E[QI$ M&CU/@[N&*V3/O@-9?N"$4ENA:R24# %)<0])#AL,@:%/H31 D'QD%9+U%A,> M)1^SZW-@ZT89C$E5H=M"I!X!K&N6>BE:]B8Z;UP/6"_LQTA/WY021!(1,QB7 M.3 :#_Z%L79!?-VQ&&]'*P5368,Y+[6@6FG=1+B]&R )5DIVAU>4.&-\N@-B MZSX"MB!7FI'?WSF%*N*E\8DL8^:A =-9@^@JZ39Y25XE'!1DE?*]-W4Z%X(1 M>]P!PC!?8^U0%RD%!?"B])JLY[0.&[?.D:-E(B A9 9)Z<=._>G>I0U25^EJ M*@T @OG^MEO=W7[/\Z7O;GN^.G]$$R!]8+F"Z6SR"K:]S@V&ULC511;YLP$'[?KS@Q M:6JE*A!HNZY+D)*VTS:I4]6HV\.T!P<.L&IL:IO0_?N=#6&9ED9] ?M\W^?O M;'\WZY1^-!6BA>=:2#,/*FN;RS T684U,Q/5H*250NF:69KJ,C2-1I9[4"W" M.(K.PYIQ&:0S'[O3Z4RU5G")=QI,6]=,_UZB4-T\F ;;P#TO*^L"83IK6(DK MM _-G:99.++DO$9IN)*@L9@'B^GE\M3E^X3O'#NS,P97R5JI1S?YDL^#R E" M@9EU#(Q^&[Q"(1P1R7@:.(-Q2P?<'6_9/_G:J98U,WBEQ ^>VVH>7 208\%: M8>]5]QF'>LX<7Z:$\5_H^MSX0P!9:ZRJ!S IJ+GL_^QY.(<=P$7T B > +'7 MW6_D55XSR]*95AUHETUL;N!+]6@2QZ6[E)75M,H)9]-5NS;XU**T<+.AKYF% MEFC=8I@-%,N>(GZ!XAQNE;25@1N98_XO/B0YHZ9XJVD9'R2\QFP"R?0$XBB. M#_ E8XV)YSM[;8WP<[$V5M.+^+6OW)XMV<_F7')I&I;A/" ;&-0;#-)W;Z?G MT<<#6D]'K:>'V%]W'PJ/9(^6!:C783@$^8]8ZLU%2P3/4!KAS M<*9*R;T7"8PLJ[;K4+$-ER59M.*XH6UON4"BE?AF"BV]*N*MD&OB, UZ'\-2 M,4WZFD8KA[A?/0#K*&3@R"#"-V41DN,)[+N3<,K2=P5#];32]M89HV/C M6?1^^YO>=ZU;IDLN#0@L"!I-WM,CU'TGZ"=6-=Y]:V7)RWY84?-$[1)HO5"D M=)BX#<9VG/X!4$L#!!0 ( ^(2E8P'UI]^@@ "0; 9 >&PO=V]R M:W-H965T#8EAQ?TER -&VQ M6;2[0=*>\[#8!UJB;9[(I$I2<;*_?K^AKFYE==N7A)8X,]\,YTI=[+5YM%LA M''O>I#K;.96_&8QMOQ8[;D>:)>.H\ED/MYQ MJ097%_[9G;FZT+E+I1)WAME\M^/FY:U(]?YR$ ZJ!_=RLW7T8'QUD?&->!#N M2W9G\&M<&^'\(HI(@ M\K@+01[E.^[XU871>V9H-[C1PJOJJ0%.*CJ5!V?P5H+.7;W-+9Y8R[A*V$-Q M-$ROV8/<*+F6,5>.7<>QSI63:L/N="IC*2Q[5:U>7XP=]5(I)#^C'PUTI$E1)OHUZ&[T0\8M-PR*))%/7PF]9&F7I^LR/\ M_F4V7,G_?+@L5 *;= "@4W]B,Q^)RD)$L\R0&5[__%LXGYSWJG=;JG?9QA[EL M;&16H:]H'?*B>,W+7L?:N*Q 1A7?![V77# M[Y71I\2\5F+>J\0-MUOO17[Q_FLNGWA*'M.E0"^K;@6.\F?38;B(AO.S19\: MBUJ-Q0_.X@E,M7GI@MU+>LSN);_@ 94GR5-!OBFKIPPQ+G8K87R<_R-7@DTG MP^">[Y$-Z<1X:MG?6#B<+^;#\#3TZ^7IZ7!R>A;\B<( 5BPS.B97G$?#Q=F, M1?@W7P8X:8D$FK"-UHEEO_^VC,+PG$T7X7!Z%@:?M8,3$+O%=#D\F\ZQCH81 MUM%DR3YO!1+$+N/JA66 H1/DS#1]0<5ZH@H2.&S >2%.D@.EI T>M%)&1%K MDU .9J#5>SB>8$[C>9+3"BQB;LP+9>"&5\T".VD+"&$>O(FU=4P;IE#44:E3 M9+)5*H*"DDI8PN#*$A[!K84]*%\1'7+_(TABK1))WFZ';2&Y4?H) @APG!M# M1"A/\2-+Q9-([8C51\CV!IJ>)'JO(,, _9:;#<0Z'13@UJ6QD5B3$?NG[O/( M9>V1RUZ/O <,!0WO84T4KV,YH9=)MV]V< Z0C9?3='Q9$;& MHMI]#<>*^[=6CO23.%I6(=:F--9^*U \X88!'1!U$U48H M81#BMN)L@[71NQJ&+8Q'OZ;H@Z2RB/G4,X-E$!<2M%#_!L$$O$KR$3 :(0*;Q]N:UHBLZ S@ MZCQ#MGF6E)Q &RU8>,;"B,U#%F(]8^&4?O:X_5GM]F>];G]=9PP@8^]TOG+K M/*V:MLZJTLNP.P2ZI025%+:<#">329\^X:1I22<_*"TQ3I)]YL^B$WX_^;'R MTO \<"]>:4!ZY5#0.,PR@>//+--6UIY/^TSB+>#]S0>*T4_2^AWPI5:;C#90 M)9Q2^@T*0AWGKZBV1)/SZX<;OPK/7[/%Z>0DG, 1)1R)\*)Y6OG8,*ULX^!L M%KZ:>/_<"6YSX_M,QIT#0>Z*@UG778NM.E&62!NGF@A\Y!\HYOAC&:7B.<.@ MY',T6XGZ15$GB,@(*@&CH&T\037%Q^9A&7MI+/F-P+K\D/WXC@R&)7).WCE&;B)9UYG0H*"F*YVVI4*4I#95ZCQW_E1EJ4\/K8BW.1*%E9D85&O3[>&KO"7A]_\)63 M[(@)M\#]_IG6HM/C>YEU>_QQ";T:1(T&4:\&'S4ZJ3ND48C8@?D#:GPW^%X^ MW> [F:,%FT5GP\5L@E48A<,(J]ER.$/BFC,N] -FI?NE/0+\]PQ*8&7TJM),^F%_:/>%^N#_KTMPJ$;^R\,>=_R[47; MC'=A_WQW3X4:(7W'#05F)]A?&.F^8=N+M9GBPOXQ[@.7AOWA6^I/33HN$F%[ M=K3.Y+MCXUV_C&YM2'#P,X*IW/D"(LI.O6H UZ1",15L);(;?/'%M^M)6842 M9%J4_3?L(]$%(3MA7Q1/_D+NQ;NON:9_OG4L2R1U6>4888NT3NQ0.C%E2,P@ MJ%9>AJ@>4!=US1W..UC4YF$_X@5"TTEY4S3'!C/Q42(*C9GY4]NT\.*)[,'JE MC0_6U4M;>CF:PE$H=XHF_CPV:9DRVHK$U&"0D'K(; )8E>3V' MH>$S[H2&/(;6INK?MD@$;88>%AYU2RM]/XBK6R&_$,VMT+#I@.'(0GI56P\S M_E(^ 7&JU:8 E(B5.V:0PUUMA3&Z-;:V4I67&Z9,T'3RQ=5&Z4EMTOK2H?2% MLAN[=H=70W0%[+'2'5$PG11/#B?01":(A]XZT%R#A?WW8)A^Q3=WY$8K3?WO M\;3_"_=C/Y+3JTUSA1+VWZ%\E/",!$'="?L7KDYJAIWXQJT/%YC=-_[S#$Z: M5"R^8=1/ZT] U\6'CV9[\?WH$S<;.#Y*W!JDD]$"C8(I/LD4/YS._&<09 &G M=WZY%1SYB#;@_5HC!98_2$#]8>SJ?U!+ P04 " /B$I6[N<&&+@" "T M!0 &0 'AL+W=O=7$.Y0 M;(!1?Z5.TB8&DG;%-J!8T'3K8=A!L1E'J"UYDMRT^_6CY"3K@#38Q:)H\O&1 M(CG>2/6HUX@&GNM*Z(FW-J:Y" *=K[%F^DPV*.C/2JJ:&;JJ,M"-0E8XI[H* MXC!,@YIQX65CIYNK;"Q;4W&!(U";&(C ZGO *J\H"$8U?6TQO'](ZOI9WZ#R>J!%V8]\88>%+AB M;67NY.83;O,YMWBYK+3[PF9K&WJ0M]K(>NM,#&HNNI,];^OP/P[QUB%VO+M MCN4U,RP;*[D!9:T)S0HN5>=-Y+BPC[(PBOYR\C/9K-6DT1J8*O0S(%2QX M*?B*YTP8F.:Y;(7AHH2YK'C.4[:L4'\8!X986*P@WT:<=1'C-R*F<"N% M66OX* HL_O4/B/T^A7B7PBP^"GB-^1DDD0]Q&,='\))]21*'=_X&WE=5,L%_ M,]LU/EQ)H2GI@G5-1%6:*]0H3*>@4MUPP43.604+4B)UK-'P8[K41E'/_3Q4 MH8Y @\TTP0%C9*Y;=,T]@>CCJ'_VV2U3)1<:*ER1:W@VH'Y3W8[H+D8V;BZ7TM"4.W%-:Q65-:#_*RG- M[F(#[!=U]@=02P,$% @ #XA*5HQ]/16Y @ *08 !D !X;"]W;W)K M&ULE57;;MI $'WG*T9.%342PA<@H0E8@B154RDM M"KFHJOJPV(.]RMI+=M=8IHX#43N9XX MJ3'K<]?548H9TSVYQIQN5E)ES-!6):Y>*V1Q!J9LQGCOAN#J;JW L M"R-XCG,%NL@RIMYF*&0Y<7QG>W#'D]38 S<F<--I*EE,]VHA"6B&2\ M-)Q.Z]("=]=;]L]5[!3+DFF\E.*)QR:=.",'8ERQ0I@[67[!)IZAY8NDT-4( M96W;]QR("FUDUH!)0<;S>F:OS7?8 8S> P0-(*ATUXXJE5?,L'"L9 G*6A.; M752A5F@2QW/[* NCZ)83SH37+P4W;_#QGBT%ZI.Q:XC47KE10S"K"8)W"$[A M5N8FU7"=QQC_C7=)3*LHV"J:!0<)KS#J0=_O0N %P0&^?AMAO^(;'H[PYW2I MC:(D^+4OQIJBOY_"%L:Y7K,()PYEOD:U02<\/O)/O8L# @>MP,$A]G!!A187 M D&NH&1*L=SH.EM)]SZQ!^GVBSWH [X5V1(5/)FX!]--TMM939-$8<(,=@AY M_8HJXAKA#FV]\SR!F]PH3B4:=18I(W5P<&XZ-1X/L7V[GSM%7(M2XP!B-A7BP%C\C=!JDFE":L'_C= M8.C!H.=Y^R /E)"J5-P@F0]'W:%G;0?>OU(HX;"*?YMTEOOL4_>LY@YH&,*' M5ESS$6R]_#\:]N6+NU.^&:JD:E(:(EGDIJ[D]K3M@].Z_/^8UTWTEJF$G@,$ MK@CJ]NJ&2REH=92+5/JY:BL =VOI#3;C770_AW"WU!+ P04 M " /B$I6AX]6\T<$ !O% &0 'AL+W=O+SGXDEN"%'@.8F9G%@;I;:7MBW# M#4FPO.!;PO0W*RX2K/2M6-MR*PB.\J DMI'C^':"*;.FX_S97$S'/%4Q960N M@$R3!(L?5R3F^XD%K<.#![K>J.R!/1UO\9HLB'K;Q-QJIS<0:6B B*YS&ZH'OOY)2D)?AA3R6 M^7^P+\R"RT1HMN\ASDT=K-91ER[A00G]+=9R:7J52/Y$28!:!1;&6@*_ M@JX97=$0,P5F8"6121JQMM:4J4+'71=(2/@#0DO@ M_ M!"W@SG;Z(QFE6LV!!PE10E:7Q]CF, M4ZT8K 1/P#5/MJG">7WK-;C%@NFD2S G BPV6!#P_4\-#.X42>0_75DN6+C= M++*6<"FW."032^]Y2<2.6--??H*^\WM7BGH":R1L4"5L8$*?/N"]+G-%!,6Q M[%):A/MY>-:K=E/H!SXN< M$&N/< /HCF WLZ!B%AB9_<45CKL(!:WI8. .1ZY_0BMHK2="[A Y+V1L6/$: M&GG-8OU"PRPD0+\:0<33I5JEL7[+Y*VO,X7#%I.AH_].^!JG?>[KUR4"T'F9LS%D(;%VFL>3/&V0O8 M$UI3<6TOX,?P%[!7@]$76C-IM<6 9H_QUJH?M*L>(HC:56^<[KUR:D<"7[$D MAZI_U!Y:['4%$/'*%C "GKV:/:$UY=>6!_H?8PL8K=?92>L)K9FTVHU!LQU[ MZQ9HNS-OZ+6\CGFR]XJI+1PT>[@'(I6@H=)K_;KE,6.=O8S_A\V#M<^#HX]1 M^[T:Q;[0F@<$M5-$1E/UUMHO41H_A+P.HV^>[5PU]M&13D+$.C_IDB#_-5*< M[E1/J].T67Z&9-?#BZ.X>RS6E$D0DY4.=2X"746B.-TJ;A3?Y@=$2ZX43_++ M#<'Z'9(-T-^O.%>'FVR"ZHQQ^A]02P,$% @ #XA*5C.HK"^]! KQT M !D !X;"]W;W)K&ULM5EKC^(V%/TK5EI5N])T M@LWPF@(2CXYVI)T6S>QL/ZSV@TDNQ-K$IK:!K=0?7^8 Q[NA?RF(@"-OBBJV.&8>%1&J;)%3^,X58[$<>]EX&'MDZTNF M/QYNZ!J>0#]O%M+<^25*R!+@B@F.)*Q&W@3?SD@_#G,?CKQ6FA'$$.@4@IJW'P_0$&HD^(%(E;9*]H7
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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 84 151 1 false 39 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://neovolta.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Balance Sheets (Unaudited) Sheet http://neovolta.com/role/BalanceSheets Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/BalanceSheetsParenthetical Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Statements of Operations (Unaudited) Sheet http://neovolta.com/role/StatementsOfOperations Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical) Sheet http://neovolta.com/role/StatementsOfOperationsParenthetical Statements of Operations (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Statements of Stockholders' Equity (Unaudited) Sheet http://neovolta.com/role/StatementsOfStockholdersEquity Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Statements of Cash Flows (Unaudited) Sheet http://neovolta.com/role/StatementsOfCashFlows Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Business and Summary of Significant Accounting Policies Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies Business and Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Notes Payable Notes http://neovolta.com/role/NotesPayable Notes Payable Notes 9 false false R10.htm 00000010 - Disclosure - Equity Sheet http://neovolta.com/role/Equity Equity Notes 10 false false R11.htm 00000011 - Disclosure - Commitments and Contingencies Sheet http://neovolta.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 00000012 - Disclosure - Subsequent Events Sheet http://neovolta.com/role/SubsequentEvents Subsequent Events Notes 12 false false R13.htm 00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies Business and Summary of Significant Accounting Policies (Policies) Policies http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 13 false false R14.htm 00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables Business and Summary of Significant Accounting Policies (Tables) Tables http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Equity (Tables) Sheet http://neovolta.com/role/EquityTables Equity (Tables) Tables http://neovolta.com/role/Equity 15 false false R16.htm 00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory Business and Summary of Significant Accounting Policies (Details Inventory) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 16 false false R17.htm 00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative) Sheet http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative Business and Summary of Significant Accounting Policies (Details Narrative) Details http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables 17 false false R18.htm 00000018 - Disclosure - Notes Payable (Details Narrative) Notes http://neovolta.com/role/NotesPayableDetailsNarrative Notes Payable (Details Narrative) Details http://neovolta.com/role/NotesPayable 18 false false R19.htm 00000019 - Disclosure - Equity (Details - Warrant activity) Sheet http://neovolta.com/role/EquityDetails-WarrantActivity Equity (Details - Warrant activity) Details http://neovolta.com/role/EquityTables 19 false false R20.htm 00000020 - Disclosure - Equity (Details Narrative) Sheet http://neovolta.com/role/EquityDetailsNarrative Equity (Details Narrative) Details http://neovolta.com/role/EquityTables 20 false false All Reports Book All Reports neovolta_i10q-123122.htm neov-20221231.xsd neov-20221231_cal.xml neov-20221231_def.xml neov-20221231_lab.xml neov-20221231_pre.xml neovolta_ex3101.htm neovolta_ex3102.htm neovolta_ex3201.htm neovolta_ex3202.htm image_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 38 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "neovolta_i10q-123122.htm": { "axisCustom": 0, "axisStandard": 13, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 308, "http://xbrl.sec.gov/dei/2022": 34 }, "contextCount": 84, "dts": { "calculationLink": { "local": [ "neov-20221231_cal.xml" ] }, "definitionLink": { "local": [ "neov-20221231_def.xml" ] }, "inline": { "local": [ "neovolta_i10q-123122.htm" ] }, "labelLink": { "local": [ "neov-20221231_lab.xml" ] }, "presentationLink": { "local": [ "neov-20221231_pre.xml" ] }, "schema": { "local": [ "neov-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 278, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 19, "http://neovolta.com/20221231": 1, "http://xbrl.sec.gov/dei/2022": 7, "total": 27 }, "keyCustom": 11, "keyStandard": 140, "memberCustom": 27, "memberStandard": 11, "nsprefix": "NEOV", "nsuri": "http://neovolta.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://neovolta.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - Equity", "menuCat": "Notes", "order": "10", "role": "http://neovolta.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "11", "role": "http://neovolta.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "12", "role": "http://neovolta.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - Business and Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "13", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Business and Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "NEOV:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - Business and Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "14", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables", "shortName": "Business and Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - Equity (Tables)", "menuCat": "Tables", "order": "15", "role": "http://neovolta.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - Business and Summary of Significant Accounting Policies (Details Inventory)", "menuCat": "Details", "order": "16", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory", "shortName": "Business and Summary of Significant Accounting Policies (Details Inventory)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterials", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashUninsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - Business and Summary of Significant Accounting Policies (Details Narrative)", "menuCat": "Details", "order": "17", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "Business and Summary of Significant Accounting Policies (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashUninsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-08-012022-08-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ConversionOfStockAmountConverted1", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - Notes Payable (Details Narrative)", "menuCat": "Details", "order": "18", "role": "http://neovolta.com/role/NotesPayableDetailsNarrative", "shortName": "Notes Payable (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - Equity (Details - Warrant activity)", "menuCat": "Details", "order": "19", "role": "http://neovolta.com/role/EquityDetails-WarrantActivity", "shortName": "Equity (Details - Warrant activity)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Balance Sheets (Unaudited)", "menuCat": "Statements", "order": "2", "role": "http://neovolta.com/role/BalanceSheets", "shortName": "Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - Equity (Details Narrative)", "menuCat": "Details", "order": "20", "role": "http://neovolta.com/role/EquityDetailsNarrative", "shortName": "Equity (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-08-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Balance Sheets (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://neovolta.com/role/BalanceSheetsParenthetical", "shortName": "Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Statements of Operations (Unaudited)", "menuCat": "Statements", "order": "4", "role": "http://neovolta.com/role/StatementsOfOperations", "shortName": "Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Statements of Operations (Unaudited) (Parenthetical)", "menuCat": "Statements", "order": "5", "role": "http://neovolta.com/role/StatementsOfOperationsParenthetical", "shortName": "Statements of Operations (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-10-012022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "AsOf2021-06-30_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Statements of Stockholders' Equity (Unaudited)", "menuCat": "Statements", "order": "6", "role": "http://neovolta.com/role/StatementsOfStockholdersEquity", "shortName": "Statements of Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2021-07-012021-09-30_us-gaap_CommonStockMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000007 - Statement - Statements of Cash Flows (Unaudited)", "menuCat": "Statements", "order": "7", "role": "http://neovolta.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - Business and Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies", "shortName": "Business and Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - Notes Payable", "menuCat": "Notes", "order": "9", "role": "http://neovolta.com/role/NotesPayable", "shortName": "Notes Payable", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "neovolta_i10q-123122.htm", "contextRef": "From2022-07-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 39, "tag": { "NEOV_AdjustmentForChangeInAccountingPrinciple": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjustment for change in accounting principle" } } }, "localname": "AdjustmentForChangeInAccountingPrinciple", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "NEOV_AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Adjustment of debt discount related to adoption of new accounting principle" } } }, "localname": "AdjustmentOfDebtDiscountRelatedToAdoptionOfNewAccountingPrinciple", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NEOV_AmortizedValueOfNewCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of New Compensation Plan [Member]" } } }, "localname": "AmortizedValueOfNewCompensationPlanMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfRSUsGrantedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value of RSUs Granted [Member]" } } }, "localname": "AmortizedValueOfRSUsGrantedMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesGrantedToAttorneyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares Granted To Attorney [Member]" } } }, "localname": "AmortizedValueOfSharesGrantedToAttorneyMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesGrantedToVariousAdvisorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares Granted To Various Advisors [Member]" } } }, "localname": "AmortizedValueOfSharesGrantedToVariousAdvisorsMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AmortizedValueOfSharesToNewIndependentDirectorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amortized Value Of Shares To New Independent Director [Member]" } } }, "localname": "AmortizedValueOfSharesToNewIndependentDirectorMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_AnotherDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Another Dealer [Member]" } } }, "localname": "AnotherDealerMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_CommonStockParValue0.001PerShareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.001 per share" } } }, "localname": "CommonStockParValue0.001PerShareMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "NEOV_ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Conversion of convertible debt and accrued interest into common stock" } } }, "localname": "ConversionOfConvertibleDebtAndAccruedInterestIntoCommonStock", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "NEOV_ConvertibleDebt1Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Debt 1 [Member]" } } }, "localname": "ConvertibleDebt1Member", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_DealerFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dealer Four [Member]" } } }, "localname": "DealerFourMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_DealerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dealer Three [Member]" } } }, "localname": "DealerThreeMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_DealerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dealer Two [Member]" } } }, "localname": "DealerTwoMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_FairValueOfBonusSharesEarnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Bonus Shares Earned [Member]" } } }, "localname": "FairValueOfBonusSharesEarnedMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_FairValueOfIncentiveSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares [Member]" } } }, "localname": "FairValueOfIncentiveSharesMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_FairValueOfIncentiveSharesWholesaleDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Of Incentive Shares Wholesale Dealer [Member]" } } }, "localname": "FairValueOfIncentiveSharesWholesaleDealerMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_InterimFinancialInformationPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interim Financial Information" } } }, "localname": "InterimFinancialInformationPolicyTextBlock", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_OneDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Dealer [Member]" } } }, "localname": "OneDealerMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_PublicInvestorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Investors [Member]" } } }, "localname": "PublicInvestorsMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "domainItemType" }, "NEOV_PublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Offering [Member]" } } }, "localname": "PublicOfferingMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "NEOV_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable-0]" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExercisable", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "monetaryItemType" }, "NEOV_StockOptionPlan2019Member": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "2019 Stock Option Plan [Member]" } } }, "localname": "StockOptionPlan2019Member", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThreeGranteesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Grantees [Member]" } } }, "localname": "ThreeGranteesMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThreeIndependentDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Three Independent Directors [Member]" } } }, "localname": "ThreeIndependentDirectorsMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_ThridDealerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Thrid Dealer [Member]" } } }, "localname": "ThridDealerMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_TwoDealersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Dealers [Member]" } } }, "localname": "TwoDealersMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_TwoExecutivesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Executives [Member]" } } }, "localname": "TwoExecutivesMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "NEOV_UnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriters [Member]" } } }, "localname": "UnderwritersMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "domainItemType" }, "NEOV_WarrantsAndRightsOutstandingTermExercisable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants term, exercisable" } } }, "localname": "WarrantsAndRightsOutstandingTermExercisable", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "durationItemType" }, "NEOV_WarrantsEachWarrantExercisableForOneShareOfCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants, each warrant exercisable for one share of common stock" } } }, "localname": "WarrantsEachWarrantExercisableForOneShareOfCommonStockMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "NEOV_WarrantsExercisableShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant exercisable, shares" } } }, "localname": "WarrantsExercisableShares", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "NEOV_WarrantsExercisableWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants exercisable, weighted average exercise price" } } }, "localname": "WarrantsExercisableWeightedAverageExercisePrice", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "perShareItemType" }, "NEOV_WarrantsIssuedShares": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "[custom:WarrantsIssuedShares]" } } }, "localname": "WarrantsIssuedShares", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "NEOV_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "domainItemType" }, "NEOV_WarrantsUnderwritersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants Underwriters [Member]" } } }, "localname": "WarrantsUnderwritersMember", "nsuri": "http://neovolta.com/20221231", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r344", "r346", "r347" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r333" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r348" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r336" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r339" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r335" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r340" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r341" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r338" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r337" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r126", "r127", "r201", "r227", "r316", "r318" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r174", "r330", "r371", "r405" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r174", "r330", "r371", "r405" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r126", "r127", "r201", "r227", "r317", "r318" ], "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r13", "r332" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r175", "r176" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r5", "r332" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r270", "r271", "r272", "r362", "r363", "r364", "r399" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operations:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r106", "r177", "r180", "r181", "r183" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive shares" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r84", "r90", "r102", "r125", "r163", "r166", "r170", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r281", "r283", "r289", "r332", "r369", "r370", "r402" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r98", "r109", "r125", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r281", "r283", "r289", "r332", "r369", "r370", "r402" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r33", "r101", "r314" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r29", "r33", "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r29", "r78" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net increase in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental non-cash financing activities" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash, Uninsured Amount" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r103", "r104", "r105", "r125", "r144", "r145", "r147", "r149", "r154", "r155", "r178", "r189", "r191", "r192", "r193", "r196", "r197", "r225", "r226", "r229", "r233", "r239", "r289", "r313", "r353", "r359", "r365" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price", "periodEndLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "periodStartLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity", "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Class of Warrant or Right, Outstanding", "periodStartLabel": "Class of Warrant or Right, Outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r19", "r86", "r93" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 4)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r52", "r187", "r188", "r312", "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r362", "r363", "r399" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r57" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r4", "r332" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, $0.001 par value, 100,000,000 shares authorized, 32,845,368 and 21,977,251 shares issued and outstanding" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationRelatedCostsPolicyTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.", "label": "Stock Compensation Expense" } } }, "localname": "CompensationRelatedCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r44", "r45", "r76", "r77", "r174", "r311" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r44", "r45", "r76", "r77", "r174", "r310", "r311" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r44", "r45", "r76", "r77", "r174", "r311", "r406" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r44", "r45", "r76", "r77", "r174" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk, Percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r44", "r45", "r76", "r77", "r174", "r311" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r36", "r37", "r38" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Converted", "verboseLabel": "Amounts converted" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r36", "r37", "r38" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Number of shares converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtMember": { "auth_ref": [ "r54", "r198", "r199", "r210", "r211", "r212", "r216", "r217", "r218", "r219", "r220", "r325", "r326", "r327", "r328", "r329" ], "lang": { "en-us": { "role": { "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt [Member]" } } }, "localname": "ConvertibleDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r18" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable, Noncurrent", "verboseLabel": "Convertible notes payable" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible notes payable" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r24", "r302" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r43", "r174" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r36", "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r36", "r38" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Shares converted" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r56", "r123", "r203", "r204", "r205", "r206", "r207", "r208", "r209", "r214", "r221", "r222", "r224" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Notes Payable" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r55", "r200" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r17", "r199" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r18", "r58", "r59", "r60", "r61", "r79", "r80", "r82", "r89", "r128", "r198", "r199", "r200", "r201", "r202", "r204", "r210", "r211", "r212", "r213", "r215", "r216", "r217", "r218", "r219", "r220", "r223", "r297", "r325", "r326", "r327", "r328", "r329", "r360" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationLiabilityCurrentAndNoncurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements. Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Accrued compensation expenses" } } }, "localname": "DeferredCompensationLiabilityCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r117", "r134", "r135", "r136", "r137", "r138", "r142", "r144", "r147", "r148", "r149", "r151", "r287", "r288", "r303", "r304", "r322" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r117", "r134", "r135", "r136", "r137", "r138", "r144", "r147", "r148", "r149", "r151", "r287", "r288", "r303", "r304", "r322" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r41", "r42" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r57", "r96", "r113", "r114", "r115", "r129", "r130", "r131", "r133", "r139", "r141", "r153", "r179", "r241", "r270", "r271", "r272", "r279", "r280", "r286", "r290", "r291", "r292", "r293", "r294", "r295", "r298", "r305", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r74", "r75" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Measurements and Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r25" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r23", "r125", "r163", "r165", "r169", "r171", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r289", "r324", "r369" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r112", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in current assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Other, net" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidInsurance": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for insurance that provides economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Insurance", "negatedLabel": "Prepaid insurance and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidInsurance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r81", "r88", "r116", "r162", "r296" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r119", "r121", "r122" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r354" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r108", "r315", "r332" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory", "totalLabel": "Total" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r100", "r107", "r152", "r184", "r185", "r186", "r301", "r319" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventory" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r356" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r51", "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r355" ], "calculation": { "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work in process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r14", "r125", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r282", "r283", "r284", "r289", "r323", "r369", "r402", "r403" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r85", "r92", "r332", "r361", "r367", "r401" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Stockholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r16", "r99", "r125", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r282", "r283", "r284", "r289", "r332", "r369", "r402", "r403" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r73" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Liabilities, Fair Value Disclosure" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r18", "r53" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r120" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash flows provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r29", "r30", "r32" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r22", "r32", "r87", "r94", "r97", "r110", "r111", "r115", "r125", "r132", "r134", "r135", "r136", "r137", "r140", "r141", "r146", "r163", "r165", "r169", "r171", "r178", "r189", "r190", "r191", "r192", "r193", "r194", "r195", "r196", "r197", "r288", "r289", "r324", "r369" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://neovolta.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows", "http://neovolta.com/role/StatementsOfOperations", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r26" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r163", "r165", "r169", "r171", "r324" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r1", "r40", "r49", "r72" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "Business and Summary of Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r397" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r358" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid insurance and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r28" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from convertible notes payable", "verboseLabel": "Proceeds from Convertible Debt" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r27" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Underwritten public offering of common stock", "verboseLabel": "Proceeds from Issuance Initial Public Offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r27" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from Issuance or Sale of Equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r118", "r182" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r71", "r95", "r404" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r71" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Costs" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r6", "r62", "r91", "r308", "r309", "r332" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r96", "r129", "r130", "r131", "r133", "r139", "r141", "r179", "r270", "r271", "r272", "r279", "r280", "r286", "r305", "r307" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r160", "r161", "r164", "r167", "r168", "r172", "r173", "r174", "r242", "r243", "r302" ], "calculation": { "http://neovolta.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenues from contracts with customers" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionAllowances": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue recognition for sales allowances.", "label": "Allowance for Doubtful Accounts" } } }, "localname": "RevenueRecognitionAllowances", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r320", "r321" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r174", "r366" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r41" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsInventory" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r2", "r10", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of inventory" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r63", "r66" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of warrants activity" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesFinancingTransactionAxis": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.", "label": "Securities Financing Transaction [Axis]" } } }, "localname": "SecuritiesFinancingTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SecuritiesFinancingTransactionTypeDomain": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Measurement of financing transaction securities held." } } }, "localname": "SecuritiesFinancingTransactionTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r31" ], "calculation": { "http://neovolta.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r258" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r69" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Number of shares exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Beginning Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r103", "r104", "r105", "r125", "r144", "r145", "r147", "r149", "r154", "r155", "r178", "r189", "r191", "r192", "r193", "r196", "r197", "r225", "r226", "r229", "r233", "r239", "r289", "r313", "r353", "r359", "r365" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r21", "r57", "r96", "r113", "r114", "r115", "r129", "r130", "r131", "r133", "r139", "r141", "r153", "r179", "r241", "r270", "r271", "r272", "r279", "r280", "r286", "r290", "r291", "r292", "r293", "r294", "r295", "r298", "r305", "r306", "r307" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative", "http://neovolta.com/role/NotesPayableDetailsNarrative", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r129", "r130", "r131", "r153", "r302" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/Cover", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensation": { "auth_ref": [ "r65", "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, after Forfeiture" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockGrantedDuringPeriodValueSharebasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares granted under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Granted, Value, Share-Based Payment Arrangement, before Forfeiture" } } }, "localname": "StockGrantedDuringPeriodValueSharebasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r20", "r57", "r58", "r62", "r215" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Issuance of common stock for conversion of debt and accrued interest, shares" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r3", "r4", "r57", "r62" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock in underwritten public offering, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r3", "r4", "r57", "r62" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock compensation expense, shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r21", "r57", "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Issuance of common stock for conversion of debt and accrued interest" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r3", "r4", "r57", "r62" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of common stock in underwritten public offering" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r3", "r4", "r62", "r68" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock compensation expense" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r4", "r7", "r8", "r50", "r332", "r361", "r367", "r401" ], "calculation": { "http://neovolta.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets", "http://neovolta.com/role/StatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r64", "r124", "r226", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r241", "r285" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r299", "r300" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "Liquidity" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TransactionDomain": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Agreement between buyer and seller for the exchange of financial instruments." } } }, "localname": "TransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TransactionTypeAxis": { "auth_ref": [ "r318" ], "lang": { "en-us": { "role": { "documentation": "Information by type of agreement between buyer and seller for the exchange of financial instruments.", "label": "Transaction Type [Axis]" } } }, "localname": "TransactionTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r46", "r47", "r48", "r156", "r157", "r158", "r159" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/BusinessAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r400" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/EquityDetails-WarrantActivity" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r143", "r149" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r142", "r149" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://neovolta.com/role/StatementsOfOperationsParenthetical" ], "xbrltype": "sharesItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r333": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r334": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r335": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r336": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r337": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r338": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r339": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r341": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r342": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r343": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r344": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r345": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r346": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r347": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r348": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r349": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r351": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r352": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128088960&loc=d3e3913-113898", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f(1))", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126965701&loc=d3e15009-113911", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 39 0001683168-23-000747-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-23-000747-xbrl.zip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